| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 | 6.12e-16 | 38 | 185 | 12 | GO:0000146 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | KIF13B MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B DNAH7 KIF15 DNAH17 MYH15 DNAH5 | 8.03e-16 | 118 | 185 | 17 | GO:0003774 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF13B MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 EP400 MYH7B DDX42 NVL AK6 SRCAP DNAH7 ATP2C1 MDN1 KIF15 CCT5 DNAH17 MYH15 POLQ DNAH5 VCP | 1.82e-11 | 614 | 185 | 27 | GO:0140657 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 IQGAP2 MAP2 SPTAN1 CAMKV MYH15 CNGA2 PCNT | 5.07e-11 | 230 | 185 | 17 | GO:0005516 |
| GeneOntologyMolecularFunction | actin filament binding | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 IQGAP2 MYH7B SPTAN1 FHOD3 MYH15 PLEC | 3.87e-10 | 227 | 185 | 16 | GO:0051015 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF13B MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 IQGAP2 MAP2 MYH7B SPTAN1 CEP290 NUMA1 FHOD3 DAXX CCDC61 KLHL20 MAP3K1 TAOK2 BICDL1 STX1A BRCA1 KIF15 CCT5 ANLN SYNE2 MYH15 PLEC MYBPC2 | 1.93e-09 | 1099 | 185 | 33 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 IQGAP2 MAP2 MYH7B SPTAN1 FHOD3 KLHL20 ANLN SYNE2 MYH15 PLEC MYBPC2 | 4.01e-09 | 479 | 185 | 21 | GO:0003779 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF13B MYH3 MYH4 MYH7 MYH8 DDX42 NVL AK6 SRCAP DNAH7 ATP2C1 MDN1 KIF15 CCT5 POLQ DNAH5 VCP | 7.99e-07 | 441 | 185 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF13B RERG MYH3 MYH4 MYH7 MYH8 DDX42 NVL AK6 SRCAP DNAH7 ATP2C1 MDN1 KIF15 CCT5 EIF5B POLQ DNAH5 VCP | 1.11e-04 | 775 | 185 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF13B RERG MYH3 MYH4 MYH7 MYH8 DDX42 NVL AK6 SRCAP DNAH7 ATP2C1 MDN1 KIF15 CCT5 EIF5B POLQ DNAH5 VCP | 3.04e-04 | 839 | 185 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF13B RERG MYH3 MYH4 MYH7 MYH8 DDX42 NVL AK6 SRCAP DNAH7 ATP2C1 MDN1 KIF15 CCT5 EIF5B POLQ DNAH5 VCP | 3.09e-04 | 840 | 185 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF13B RERG MYH3 MYH4 MYH7 MYH8 DDX42 NVL AK6 SRCAP DNAH7 ATP2C1 MDN1 KIF15 CCT5 EIF5B POLQ DNAH5 VCP | 3.09e-04 | 840 | 185 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.81e-04 | 70 | 185 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | JUN kinase binding | 4.84e-04 | 17 | 185 | 3 | GO:0008432 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | DCAF6 NUP98 DAXX SRCAP CITED2 RNF14 BRCA1 PRKCB CTBP1 THRAP3 | 5.46e-04 | 303 | 185 | 10 | GO:0003713 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.76e-04 | 18 | 185 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 6.64e-04 | 43 | 185 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | histone binding | 8.43e-04 | 265 | 185 | 9 | GO:0042393 | |
| GeneOntologyMolecularFunction | myosin phosphatase activity | 1.17e-03 | 85 | 185 | 5 | GO:0017018 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein reader activity | 1.55e-03 | 25 | 185 | 3 | GO:0140035 | |
| GeneOntologyMolecularFunction | cAMP binding | 1.55e-03 | 25 | 185 | 3 | GO:0030552 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.55e-03 | 25 | 185 | 3 | GO:0017056 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 1.94e-03 | 27 | 185 | 3 | GO:0004709 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 2.40e-09 | 15 | 187 | 6 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 8.69e-09 | 18 | 187 | 6 | GO:0033275 | |
| GeneOntologyBiologicalProcess | organelle assembly | MYH3 IFT140 MYH6 MYH7 MYH10 MYH11 CNTRL CEP290 NUMA1 FHOD3 NUDCD3 CCDC61 DNAH7 AK7 SH3PXD2B MDN1 BRCA1 KIF15 ANLN CEP250 DNAH17 SYNE2 EIF5B PRKDC FAM149B1 PLEC PAN3 PIBF1 DNAH5 HYDIN PCNT MYBPC2 | 1.03e-08 | 1138 | 187 | 32 | GO:0070925 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 IQGAP2 MYH7B SPTAN1 FHOD3 MAP3K1 TAOK2 SH3PXD2B FAT1 ATP2C1 RAPGEF3 ANLN ARHGAP44 SYNE2 ATXN3 IQSEC1 PLEC POTEJ PDCD10 MYBPC2 | 1.54e-08 | 912 | 187 | 28 | GO:0030029 |
| GeneOntologyBiologicalProcess | actomyosin structure organization | MYH3 MYH6 MYH7 MYH9 MYH10 MYH11 IQGAP2 FHOD3 SH3PXD2B RAPGEF3 ANLN PLEC PDCD10 MYBPC2 | 4.06e-08 | 239 | 187 | 14 | GO:0031032 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | MYH3 MYH6 MYH7 MYH10 MYH11 NUMA1 FHOD3 CCDC61 SH3PXD2B MDN1 BRCA1 KIF15 ANLN EIF5B PRKDC PLEC PAN3 PIBF1 MYBPC2 | 7.07e-08 | 475 | 187 | 19 | GO:0140694 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH3 MYH6 MYH7 MYH9 MYH10 MYH11 IQGAP2 SPTAN1 FHOD3 MAP3K1 TAOK2 SH3PXD2B FAT1 ATP2C1 RAPGEF3 ANLN ARHGAP44 ATXN3 IQSEC1 PLEC POTEJ PDCD10 MYBPC2 | 1.11e-06 | 803 | 187 | 23 | GO:0030036 |
| GeneOntologyBiologicalProcess | myofibril assembly | 1.14e-06 | 86 | 187 | 8 | GO:0030239 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.38e-06 | 153 | 187 | 10 | GO:0030048 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 1.48e-06 | 89 | 187 | 8 | GO:0055002 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MYH9 MAP2 CNTRL CEP290 NTMT1 NUMA1 CCDC61 DNAH7 AK7 BRCA1 KIF15 CEP250 DNAH17 SYNE2 PDE4DIP ATXN3 PIBF1 DNAH5 HYDIN VCP PCNT | 2.54e-06 | 720 | 187 | 21 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF13B IFT140 MYH9 MAP2 CNTRL CEP290 NTMT1 NUMA1 CCDC61 DNAH7 AK7 BICDL1 RSPH3 BRCA1 KIF15 CEP250 DNAH17 SYNE2 PDE4DIP ATXN3 PIBF1 DNAH5 HYDIN VCP PCNT | 1.11e-05 | 1058 | 187 | 25 | GO:0007017 |
| GeneOntologyBiologicalProcess | sarcomere organization | 1.55e-05 | 59 | 187 | 6 | GO:0045214 | |
| GeneOntologyBiologicalProcess | cell cycle process | EME1 MYH9 MYH10 IQGAP2 MIS18A HJURP NTMT1 NUMA1 RAD21L1 DAXX CCDC61 NCAPG2 USP19 ZWINT TAOK2 CENPP BRCA1 KIF15 ANLN CEP250 PDE4DIP PRKCB CCAR2 PRKDC PLEC PIBF1 CPSF3 TP53BP1 VCP PCNT | 1.62e-05 | 1441 | 187 | 30 | GO:0022402 |
| GeneOntologyBiologicalProcess | nucleus organization | 2.57e-05 | 170 | 187 | 9 | GO:0006997 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 5.43e-05 | 145 | 187 | 8 | GO:0001578 | |
| GeneOntologyBiologicalProcess | cilium assembly | IFT140 CNTRL CEP290 NUDCD3 DNAH7 AK7 CEP250 DNAH17 SYNE2 FAM149B1 PIBF1 DNAH5 HYDIN PCNT | 5.65e-05 | 444 | 187 | 14 | GO:0060271 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYH3 KRT7 MYH6 MYH7 MYH9 MYH10 MYH11 KRT14 IQGAP2 MAP2 SPTAN1 NUMA1 FHOD3 MAP3K1 SH3PXD2B FAT1 KRT75 RAPGEF3 PDE4DIP PLEC PDCD10 MYBPC2 | 5.89e-05 | 957 | 187 | 22 | GO:0097435 |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly | 5.92e-05 | 9 | 187 | 3 | GO:0000915 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in cytokinesis | 5.92e-05 | 9 | 187 | 3 | GO:0000912 | |
| GeneOntologyBiologicalProcess | muscle contraction | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH11 MYH7B PVALEF KCNB2 CHRM2 MYBPC2 | 7.72e-05 | 400 | 187 | 13 | GO:0006936 |
| GeneOntologyBiologicalProcess | actomyosin contractile ring organization | 8.40e-05 | 10 | 187 | 3 | GO:0044837 | |
| GeneOntologyBiologicalProcess | CENP-A containing chromatin assembly | 8.40e-05 | 10 | 187 | 3 | GO:0034080 | |
| GeneOntologyBiologicalProcess | chromatin remodeling at centromere | 8.40e-05 | 10 | 187 | 3 | GO:0031055 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 9.09e-05 | 156 | 187 | 8 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 9.09e-05 | 156 | 187 | 8 | GO:0010927 | |
| GeneOntologyBiologicalProcess | nuclear pore complex assembly | 1.15e-04 | 11 | 187 | 3 | GO:0051292 | |
| GeneOntologyBiologicalProcess | cilium organization | IFT140 CNTRL CEP290 NUDCD3 DNAH7 AK7 CEP250 DNAH17 SYNE2 FAM149B1 PIBF1 DNAH5 HYDIN PCNT | 1.18e-04 | 476 | 187 | 14 | GO:0044782 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular transport | 1.18e-04 | 162 | 187 | 8 | GO:0032388 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | IFT140 MYH10 CNTRL CEP290 NUDCD3 DNAH7 AK7 ANLN CEP250 ARHGAP44 DNAH17 SYNE2 FAM149B1 PIBF1 DNAH5 HYDIN PCNT | 1.34e-04 | 670 | 187 | 17 | GO:0120031 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.61e-04 | 127 | 187 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | positive regulation of protein transport | MYH9 MYH10 UACA CEP290 HNRNPM ATP2C1 BRCA1 RAPGEF3 PRKCB PDCD10 PCNT | 1.66e-04 | 319 | 187 | 11 | GO:0051222 |
| GeneOntologyBiologicalProcess | cell projection assembly | IFT140 MYH10 CNTRL CEP290 NUDCD3 DNAH7 AK7 ANLN CEP250 ARHGAP44 DNAH17 SYNE2 FAM149B1 PIBF1 DNAH5 HYDIN PCNT | 1.74e-04 | 685 | 187 | 17 | GO:0030031 |
| GeneOntologyBiologicalProcess | heart development | SIN3B IFT140 MYH6 MYH7 MYH10 MYH11 NSD2 CNTRL CEP290 FHOD3 CITED2 SH3PXD2B ALDH1A2 DCHS1 PRKDC PLEC DNAH5 PCNT | 1.90e-04 | 757 | 187 | 18 | GO:0007507 |
| GeneOntologyBiologicalProcess | spindle organization | 2.14e-04 | 224 | 187 | 9 | GO:0007051 | |
| GeneOntologyBiologicalProcess | organelle localization | MYH9 MYH10 MAP2 CEP290 NUMA1 NUP98 TMIGD3 RAD21L1 ZWINT BICDL1 STX1A MDN1 STXBP2 SYNE2 CTBP1 PIBF1 PDCD10 | 2.36e-04 | 703 | 187 | 17 | GO:0051640 |
| GeneOntologyBiologicalProcess | post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery | 2.44e-04 | 3 | 187 | 2 | GO:0000973 | |
| GeneOntologyBiologicalProcess | actin filament bundle distribution | 2.44e-04 | 3 | 187 | 2 | GO:0070650 | |
| GeneOntologyBiologicalProcess | regulation of intracellular protein transport | 2.62e-04 | 182 | 187 | 8 | GO:0033157 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | MYH9 MYH10 UACA CEP290 HNRNPM ATP2C1 BRCA1 CCT5 RAPGEF3 PRKCB PDCD10 PCNT | 3.25e-04 | 403 | 187 | 12 | GO:1904951 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | MYH9 MYH10 UACA CEP290 NUMA1 HNRNPM ATP2C1 BRCA1 CCT5 RAPGEF3 CEP250 PRKCB PDCD10 EIF2AK3 PCNT | 3.34e-04 | 591 | 187 | 15 | GO:1903829 |
| GeneOntologyBiologicalProcess | regulation of protein localization | RANGAP1 MYH9 MYH10 UACA MAP2 NSD2 CEP290 NUMA1 HNRNPM NVL STX1A ATP2C1 BRCA1 CCT5 RAPGEF3 CEP250 ARHGAP44 PRKCB PDCD10 EIF2AK3 VCP PCNT | 3.59e-04 | 1087 | 187 | 22 | GO:0032880 |
| GeneOntologyBiologicalProcess | protein localization to organelle | KPNA4 IFT140 RANGAP1 NUP107 UACA MIS18A NUMA1 HNRNPM NUP98 NVL DAXX NUDCD3 VPS13D BRCA1 CCT5 CEP250 TAX1BP1 FAM149B1 PIBF1 EIF2AK3 TP53BP1 VCP | 3.77e-04 | 1091 | 187 | 22 | GO:0033365 |
| GeneOntologyBiologicalProcess | protein localization to microtubule organizing center | 4.20e-04 | 39 | 187 | 4 | GO:1905508 | |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | RANGAP1 MYH9 MYH10 UACA NSD2 CEP290 HNRNPM STX1A ATP2C1 BRCA1 CCT5 RAPGEF3 ARHGAP44 PRKCB PDCD10 PCNT | 4.42e-04 | 674 | 187 | 16 | GO:0070201 |
| GeneOntologyBiologicalProcess | intracellular transport | KPNA4 KIF13B IFT140 RANGAP1 MYH10 CCDC22 NUP107 UACA MAP2 CEP290 NUMA1 NUP98 KLHL20 NUP205 BICDL1 VPS13D STX1A MDN1 STXBP2 BRCA1 RAPGEF3 ARHGAP44 SYNE2 SNX15 PDCD10 VCP PCNT | 4.65e-04 | 1496 | 187 | 27 | GO:0046907 |
| GeneOntologyBiologicalProcess | axoneme assembly | 4.79e-04 | 109 | 187 | 6 | GO:0035082 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 4.85e-04 | 4 | 187 | 2 | GO:2000689 | |
| GeneOntologyBiologicalProcess | chromosome organization | NUP107 MIS18A HJURP NUMA1 NUP98 RAD21L1 CCDC61 NCAPG2 ZWINT CENPP KIF15 CCT5 YLPM1 PRKDC PIBF1 POLQ | 5.35e-04 | 686 | 187 | 16 | GO:0051276 |
| GeneOntologyBiologicalProcess | adult heart development | 5.41e-04 | 18 | 187 | 3 | GO:0007512 | |
| GeneOntologyBiologicalProcess | nuclear pore organization | 5.41e-04 | 18 | 187 | 3 | GO:0006999 | |
| GeneOntologyBiologicalProcess | regulation of intracellular transport | RANGAP1 UACA MAP2 CEP290 NUMA1 BRCA1 RAPGEF3 ARHGAP44 PDCD10 PCNT | 6.11e-04 | 314 | 187 | 10 | GO:0032386 |
| GeneOntologyBiologicalProcess | regulation of protein transport | RANGAP1 MYH9 MYH10 UACA CEP290 HNRNPM STX1A ATP2C1 BRCA1 RAPGEF3 ARHGAP44 PRKCB PDCD10 PCNT | 6.11e-04 | 560 | 187 | 14 | GO:0051223 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular protein transport | 6.66e-04 | 116 | 187 | 6 | GO:0090316 | |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 7.29e-04 | 45 | 187 | 4 | GO:0030866 | |
| GeneOntologyBiologicalProcess | catecholamine secretion | 7.61e-04 | 79 | 187 | 5 | GO:0050432 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | EME1 MYH10 IQGAP2 NUMA1 DAXX CCDC61 NCAPG2 ZWINT TAOK2 BRCA1 KIF15 ANLN PRKCB PRKDC PIBF1 CPSF3 VCP PCNT | 7.91e-04 | 854 | 187 | 18 | GO:1903047 |
| GeneOntologyCellularComponent | myosin filament | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 MYBPC2 | 7.83e-21 | 25 | 188 | 13 | GO:0032982 |
| GeneOntologyCellularComponent | myosin II complex | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 | 5.27e-18 | 28 | 188 | 12 | GO:0016460 |
| GeneOntologyCellularComponent | myosin complex | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 | 1.52e-13 | 59 | 188 | 12 | GO:0016459 |
| GeneOntologyCellularComponent | muscle myosin complex | 4.46e-13 | 16 | 188 | 8 | GO:0005859 | |
| GeneOntologyCellularComponent | supramolecular fiber | KIF13B MYH1 MYH2 MYH3 MYH4 KRT7 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 KRT14 IQGAP2 MAP2 MYH7B SPTAN1 NUMA1 PVALEF FHOD3 DAXX CFAP210 ARHGEF25 DNAH7 MAP3K1 KRT75 KIF15 CCT5 DNAH17 SYNE2 PDE4DIP MYH15 PLEC POTEJ DNAH5 CEP170B ALPI PCNT MYBPC2 | 1.09e-12 | 1179 | 188 | 39 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF13B MYH1 MYH2 MYH3 MYH4 KRT7 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 KRT14 IQGAP2 MAP2 MYH7B SPTAN1 NUMA1 PVALEF FHOD3 DAXX CFAP210 ARHGEF25 DNAH7 MAP3K1 KRT75 KIF15 CCT5 DNAH17 SYNE2 PDE4DIP MYH15 PLEC POTEJ DNAH5 CEP170B ALPI PCNT MYBPC2 | 1.34e-12 | 1187 | 188 | 39 | GO:0099081 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 IQGAP2 MAP2 MYH7B SPTAN1 PVALEF FHOD3 KLHL20 MAP3K1 TAOK2 SH3PXD2B STX1A RAPGEF3 ANLN PRKCB MYH15 POTEJ | 1.35e-11 | 576 | 188 | 26 | GO:0015629 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH11 MYH7B SPTAN1 PVALEF FHOD3 ARHGEF25 SYNE2 PDE4DIP MYH15 PLEC ALPI MYBPC2 | 1.77e-11 | 290 | 188 | 19 | GO:0043292 |
| GeneOntologyCellularComponent | myofibril | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH7B SPTAN1 PVALEF FHOD3 ARHGEF25 SYNE2 PDE4DIP MYH15 PLEC ALPI MYBPC2 | 5.56e-11 | 273 | 188 | 18 | GO:0030016 |
| GeneOntologyCellularComponent | sarcomere | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 SPTAN1 PVALEF FHOD3 ARHGEF25 SYNE2 PLEC MYBPC2 | 6.15e-08 | 249 | 188 | 14 | GO:0030017 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 2.22e-05 | 129 | 188 | 8 | GO:0030863 | |
| GeneOntologyCellularComponent | actomyosin contractile ring | 2.44e-05 | 7 | 188 | 3 | GO:0005826 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KIF13B KRT7 MYH9 KRT14 IQGAP2 MAP2 NUMA1 DAXX CFAP210 DNAH7 MAP3K1 KRT75 KIF15 CCT5 DNAH17 PDE4DIP PLEC POTEJ DNAH5 CEP170B PCNT | 6.26e-05 | 899 | 188 | 21 | GO:0099513 |
| GeneOntologyCellularComponent | cytoplasmic region | IFT140 RANGAP1 MAP2 CNTRL NUMA1 CFAP210 DNAH7 RSPH3 DNAH17 CTBP1 DNAH5 HYDIN | 1.07e-04 | 360 | 188 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | cell cortex | MYH2 MYH9 MYH10 IQGAP2 SPTAN1 NUMA1 DAXX RAPGEF3 ANLN PDE4DIP PRKCB CTBP1 | 1.42e-04 | 371 | 188 | 12 | GO:0005938 |
| GeneOntologyCellularComponent | Swr1 complex | 1.92e-04 | 13 | 188 | 3 | GO:0000812 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.95e-04 | 93 | 188 | 6 | GO:0030864 | |
| GeneOntologyCellularComponent | myosin II filament | 2.40e-04 | 3 | 188 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | cortical microtubule | 2.40e-04 | 3 | 188 | 2 | GO:0055028 | |
| GeneOntologyCellularComponent | contractile ring | 2.42e-04 | 14 | 188 | 3 | GO:0070938 | |
| GeneOntologyCellularComponent | microtubule | KIF13B IQGAP2 MAP2 NUMA1 DAXX CFAP210 DNAH7 KIF15 CCT5 DNAH17 PDE4DIP DNAH5 CEP170B PCNT | 3.47e-04 | 533 | 188 | 14 | GO:0005874 |
| GeneOntologyCellularComponent | brush border | 4.60e-04 | 152 | 188 | 7 | GO:0005903 | |
| GeneOntologyCellularComponent | condensed chromosome | RANGAP1 NUP107 HJURP NUP98 RAD21L1 NCAPG2 ZWINT CENPP BRCA1 TP53BP1 | 4.82e-04 | 307 | 188 | 10 | GO:0000793 |
| GeneOntologyCellularComponent | axoneme | 5.88e-04 | 207 | 188 | 8 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 6.07e-04 | 208 | 188 | 8 | GO:0097014 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | IFT140 RANGAP1 MAP2 CNTRL CFAP210 DNAH7 RSPH3 DNAH17 DNAH5 HYDIN | 6.18e-04 | 317 | 188 | 10 | GO:0032838 |
| GeneOntologyCellularComponent | microtubule associated complex | 6.48e-04 | 161 | 188 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | actomyosin | 6.69e-04 | 117 | 188 | 6 | GO:0042641 | |
| GeneOntologyCellularComponent | cortical microtubule cytoskeleton | 7.90e-04 | 5 | 188 | 2 | GO:0030981 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 9.14e-04 | 276 | 188 | 9 | GO:0000775 | |
| GeneOntologyCellularComponent | nuclear periphery | 9.24e-04 | 171 | 188 | 7 | GO:0034399 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 9.54e-04 | 223 | 188 | 8 | GO:0098862 | |
| GeneOntologyCellularComponent | DNA repair complex | 1.11e-03 | 23 | 188 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | XY body | 1.11e-03 | 23 | 188 | 3 | GO:0001741 | |
| GeneOntologyCellularComponent | kinetochore | 1.28e-03 | 181 | 188 | 7 | GO:0000776 | |
| GeneOntologyCellularComponent | nuclear body | MYH9 EP400 DDX42 HNRNPM NUP98 AK6 DAXX RDM1 SRCAP NCAPG2 KLHL20 ZWINT RBM25 PSME4 BRCA1 YLPM1 THRAP3 TP53BP1 | 1.36e-03 | 903 | 188 | 18 | GO:0016604 |
| GeneOntologyCellularComponent | dynein complex | 1.41e-03 | 54 | 188 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.42e-03 | 25 | 188 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | centrosome | IFT140 CCDC22 CNTRL CEP290 NUMA1 AK6 CCDC61 BICDL1 BRCA1 KIF15 CCT5 CEP250 PDE4DIP PRKCB PIBF1 PCNT | 1.65e-03 | 770 | 188 | 16 | GO:0005813 |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 1.85e-03 | 193 | 188 | 7 | GO:0000779 | |
| GeneOntologyCellularComponent | INO80-type complex | 1.99e-03 | 28 | 188 | 3 | GO:0097346 | |
| GeneOntologyCellularComponent | nuclear chromosome | 2.17e-03 | 254 | 188 | 8 | GO:0000228 | |
| GeneOntologyCellularComponent | lateral part of cell | 2.17e-03 | 8 | 188 | 2 | GO:0097574 | |
| GeneOntologyCellularComponent | nuclear pore | 2.20e-03 | 101 | 188 | 5 | GO:0005643 | |
| GeneOntologyCellularComponent | Z disc | 2.48e-03 | 151 | 188 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | spectrin | 2.78e-03 | 9 | 188 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 2.82e-03 | 155 | 188 | 6 | GO:0098685 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 2.83e-03 | 107 | 188 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 2.83e-03 | 107 | 188 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | centriolar subdistal appendage | 3.45e-03 | 10 | 188 | 2 | GO:0120103 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 3.45e-03 | 10 | 188 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | nuclear pore outer ring | 3.45e-03 | 10 | 188 | 2 | GO:0031080 | |
| GeneOntologyCellularComponent | I band | 3.96e-03 | 166 | 188 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | actin filament bundle | 4.30e-03 | 118 | 188 | 5 | GO:0032432 | |
| GeneOntologyCellularComponent | dendrite | RANGAP1 MYH10 URI1 MAP2 NUMA1 TMIGD3 KCNB2 CHRM2 KLHL20 ZWINT TAOK2 ARHGAP44 IGSF9B PLEC SLC9A6 GABBR1 | 4.77e-03 | 858 | 188 | 16 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | RANGAP1 MYH10 URI1 MAP2 NUMA1 TMIGD3 KCNB2 CHRM2 KLHL20 ZWINT TAOK2 ARHGAP44 IGSF9B PLEC SLC9A6 GABBR1 | 4.88e-03 | 860 | 188 | 16 | GO:0097447 |
| GeneOntologyCellularComponent | lamellipodium | 4.89e-03 | 230 | 188 | 7 | GO:0030027 | |
| GeneOntologyCellularComponent | chromosomal region | RANGAP1 NUP107 MIS18A HJURP NUP98 DAXX ZWINT CENPP PRKDC TP53BP1 | 4.93e-03 | 421 | 188 | 10 | GO:0098687 |
| GeneOntologyCellularComponent | outer dynein arm | 5.00e-03 | 12 | 188 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | dendritic growth cone | 5.00e-03 | 12 | 188 | 2 | GO:0044294 | |
| GeneOntologyCellularComponent | filopodium | 5.13e-03 | 123 | 188 | 5 | GO:0030175 | |
| GeneOntologyCellularComponent | cell leading edge | MYH9 MYH10 PDE4A IQGAP2 MAP2 FAT1 STXBP2 RAPGEF3 ARHGAP44 SYNE2 GABBR1 | 5.73e-03 | 500 | 188 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | symmetric synapse | 5.88e-03 | 13 | 188 | 2 | GO:0032280 | |
| GeneOntologyCellularComponent | cell division site | 5.89e-03 | 80 | 188 | 4 | GO:0032153 | |
| GeneOntologyCellularComponent | centriolar satellite | 6.06e-03 | 128 | 188 | 5 | GO:0034451 | |
| HumanPheno | Abnormal hand epiphysis morphology | 1.20e-05 | 59 | 69 | 7 | HP:0005924 | |
| HumanPheno | Abnormal upper limb epiphysis morphology | 2.07e-05 | 64 | 69 | 7 | HP:0003839 | |
| MousePheno | abnormal atrioventricular valve morphology | 8.15e-07 | 69 | 153 | 8 | MP:0002745 | |
| MousePheno | abnormal heart atrium and ventricle connection | 1.56e-06 | 75 | 153 | 8 | MP:0010435 | |
| MousePheno | prenatal growth retardation | SIN3B IFT140 HNF1B MYH9 MYH10 KRT14 CAND1 ZNF148 SPTAN1 FHOD3 DAXX FBXL5 STX1A ATP2C1 BRCA1 CCT5 GLDC ANLN UGDH EIF5B PIBF1 ALPI PCNT | 7.03e-05 | 869 | 153 | 23 | MP:0010865 |
| MousePheno | abnormal heart valve morphology | IFT140 MYH10 CNTRL CITED2 SH3PXD2B PSME4 TAX1BP1 DCHS1 DNAH5 | 7.60e-05 | 163 | 153 | 9 | MP:0000285 |
| MousePheno | abnormal heart and great artery attachment | IFT140 MYH10 CNTRL CEP290 CITED2 ALDH1A2 PSME4 GLDC DNAH5 PCNT | 8.59e-05 | 205 | 153 | 10 | MP:0010426 |
| MousePheno | embryonic growth retardation | HNF1B MYH9 MYH10 KRT14 CAND1 ZNF148 SPTAN1 FHOD3 DAXX FBXL5 STX1A ATP2C1 BRCA1 CCT5 GLDC ANLN UGDH EIF5B PIBF1 ALPI PCNT | 8.67e-05 | 763 | 153 | 21 | MP:0003984 |
| MousePheno | abnormal heart and great vessel attachment | IFT140 MYH10 CNTRL CEP290 CITED2 ALDH1A2 PSME4 GLDC DNAH5 PCNT | 9.69e-05 | 208 | 153 | 10 | MP:0010425 |
| MousePheno | abnormal prenatal growth/weight/body size | SIN3B IFT140 HNF1B RANGAP1 MYH8 MYH9 MYH10 KRT14 CAND1 ZNF148 NSD2 SPTAN1 CNTRL NUP98 FHOD3 DAXX FBXL5 CITED2 STX1A ALDH1A2 ATP2C1 BRCA1 CCT5 GLDC ANLN YLPM1 UGDH EIF5B PIBF1 PDCD10 ALPI PCNT | 1.43e-04 | 1493 | 153 | 32 | MP:0004196 |
| MousePheno | rhinitis | 1.46e-04 | 10 | 153 | 3 | MP:0001867 | |
| MousePheno | abnormal embryo development | HNF1B RANGAP1 MYH9 MYH10 KRT14 CAND1 ZNF148 EP400 SPTAN1 NUP98 FHOD3 DAXX SRCAP FBXL5 NUP205 CITED2 STX1A ALDH1A2 ATP2C1 BRCA1 CCT5 GLDC ANLN YLPM1 UGDH EIF5B PIBF1 PDCD10 ALPI PCNT | 1.65e-04 | 1370 | 153 | 30 | MP:0001672 |
| MousePheno | abnormal interatrial septum morphology | 1.71e-04 | 107 | 153 | 7 | MP:0000282 | |
| Domain | Myosin_N | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 | 2.41e-22 | 15 | 183 | 12 | PF02736 |
| Domain | Myosin_N | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 | 2.41e-22 | 15 | 183 | 12 | IPR004009 |
| Domain | Myosin_tail_1 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 | 9.59e-21 | 18 | 183 | 12 | PF01576 |
| Domain | Myosin_tail | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 | 9.59e-21 | 18 | 183 | 12 | IPR002928 |
| Domain | Myosin-like_IQ_dom | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 | 2.58e-20 | 19 | 183 | 12 | IPR027401 |
| Domain | - | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 | 2.58e-20 | 19 | 183 | 12 | 4.10.270.10 |
| Domain | Myosin_head_motor_dom | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 | 1.18e-15 | 38 | 183 | 12 | IPR001609 |
| Domain | MYOSIN_MOTOR | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 | 1.18e-15 | 38 | 183 | 12 | PS51456 |
| Domain | Myosin_head | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 | 1.18e-15 | 38 | 183 | 12 | PF00063 |
| Domain | MYSc | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 | 1.18e-15 | 38 | 183 | 12 | SM00242 |
| Domain | IQ | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 DCAF6 MYH10 MYH11 IQGAP2 MYH7B IQSEC1 MYH15 | 1.66e-14 | 93 | 183 | 15 | PS50096 |
| Domain | IQ_motif_EF-hand-BS | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 DCAF6 MYH10 MYH11 IQGAP2 MYH7B IQSEC1 | 2.15e-13 | 90 | 183 | 14 | IPR000048 |
| Domain | IQ | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 DCAF6 MYH10 MYH11 IQGAP2 MYH7B | 1.05e-12 | 81 | 183 | 13 | SM00015 |
| Domain | IQ | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 IQGAP2 IQSEC1 | 9.08e-11 | 71 | 183 | 11 | PF00612 |
| Domain | P-loop_NTPase | KIF13B MYH1 MYH2 RERG MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 EP400 MYH7B DDX42 NVL AK6 SRCAP DNAH7 AK7 MDN1 KIF15 HNRNPUL2 YLPM1 EIF5B MYH15 POLQ DNAH5 HYDIN VCP | 9.38e-10 | 848 | 183 | 30 | IPR027417 |
| Domain | HSA | 5.66e-04 | 4 | 183 | 2 | SM00573 | |
| Domain | HSA | 5.66e-04 | 4 | 183 | 2 | PS51204 | |
| Domain | HSA_dom | 5.66e-04 | 4 | 183 | 2 | IPR014012 | |
| Domain | HSA | 5.66e-04 | 4 | 183 | 2 | PF07529 | |
| Domain | HEAT_REPEAT | 6.18e-04 | 70 | 183 | 5 | PS50077 | |
| Domain | Prefoldin | 7.04e-04 | 72 | 183 | 5 | IPR009053 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 | 4.79e-12 | 70 | 143 | 12 | M12294 |
| Pathway | KEGG_TIGHT_JUNCTION | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B SPTAN1 PRKCB MYH15 | 6.32e-11 | 132 | 143 | 14 | M11355 |
| Pathway | REACTOME_CELL_CYCLE | RANGAP1 NUP107 NSD2 MIS18A CNTRL CEP290 HJURP NUMA1 NUP98 DAXX NCAPG2 ZWINT NUP205 CENPP PSME4 BRCA1 CEP250 SYNE2 PRKCB TP53BP1 PCNT | 6.71e-06 | 694 | 143 | 21 | M543 |
| Pathway | REACTOME_CELL_CYCLE | RANGAP1 NUP107 NSD2 MIS18A CEP290 HJURP NUMA1 NUP98 DAXX NCAPG2 ZWINT NUP205 CENPP PSME4 BRCA1 CEP250 PRKCB TP53BP1 | 3.88e-05 | 603 | 143 | 18 | MM14635 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | RANGAP1 NUP107 CNTRL CEP290 NUMA1 NUP98 ZWINT CENPP CEP250 PCNT | 4.34e-05 | 204 | 143 | 10 | M4217 |
| Pathway | REACTOME_M_PHASE | RANGAP1 NUP107 CNTRL CEP290 NUMA1 NUP98 NCAPG2 ZWINT NUP205 CENPP PSME4 CEP250 PRKCB PCNT | 8.72e-05 | 417 | 143 | 14 | M27662 |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 9.21e-05 | 24 | 143 | 4 | MM15658 | |
| Pathway | BIOCARTA_RANMS_PATHWAY | 1.16e-04 | 10 | 143 | 3 | M17370 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 1.49e-04 | 27 | 143 | 4 | M29807 | |
| Pathway | BIOCARTA_FAS_PATHWAY | 1.72e-04 | 28 | 143 | 4 | MM1396 | |
| Pathway | BIOCARTA_FAS_PATHWAY | 2.27e-04 | 30 | 143 | 4 | M9503 | |
| Pathway | BIOCARTA_HIVNEF_PATHWAY | 2.52e-04 | 56 | 143 | 5 | M13968 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | RANGAP1 MYH9 MYH10 MYH11 NUP107 IQGAP2 NUP98 ZWINT CENPP PRKCB | 2.91e-04 | 257 | 143 | 10 | MM14755 |
| Pathway | REACTOME_SUMOYLATION | 3.26e-04 | 169 | 143 | 8 | MM14919 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 4.16e-04 | 35 | 143 | 4 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 4.65e-04 | 36 | 143 | 4 | M18647 | |
| Pathway | WP_FAS_PATHWAY_AND_STRESS_INDUCTION_OF_HSP_REGULATION | 4.65e-04 | 36 | 143 | 4 | MM15967 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 5.17e-04 | 37 | 143 | 4 | M27038 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 5.73e-04 | 38 | 143 | 4 | M39549 | |
| Pathway | REACTOME_M_PHASE | RANGAP1 NUP107 CEP290 NUMA1 NUP98 NCAPG2 ZWINT NUP205 CENPP PSME4 CEP250 PRKCB | 5.79e-04 | 387 | 143 | 12 | MM15364 |
| Pathway | REACTOME_SUMOYLATION | 6.85e-04 | 189 | 143 | 8 | M27214 | |
| Pubmed | KPNA4 KIF13B MYH1 MYH2 MYH3 MYH4 EME1 KRT7 MYH6 MYH7 RANGAP1 MYH8 MYH9 MYH10 MYH11 KRT14 IQGAP2 NSD2 MYH7B SPTAN1 CNTRL DDX42 NUMA1 HNRNPM NUP98 CFAP210 SRCAP RNF17 PRPS1L1 NUP205 MIPOL1 MDN1 STXBP2 KRT75 BRCA1 SYNE2 YLPM1 EIF5B CCAR2 MYH15 PRKDC PLEC POTEJ POLQ THRAP3 CUX1 PCNT MYBPC2 | 2.58e-24 | 1442 | 191 | 48 | 35575683 | |
| Pubmed | KIF13B SIN3B RANGAP1 MYH9 MYH10 PDE4A CAND1 UACA IQGAP2 SPTAN1 NUMA1 HNRNPM TAOK2 SH3PXD2B MDN1 KIF15 CAMKV HNRNPUL2 TAX1BP1 ARHGAP44 SYNE2 PDE4DIP YLPM1 IQSEC1 DCHS1 PRKCB CCAR2 CTBP1 THRAP3 GOLGA1 CEP170B CUX1 TP53BP1 PCNT ANKS1A | 6.50e-19 | 963 | 191 | 35 | 28671696 | |
| Pubmed | 1.35e-16 | 7 | 191 | 7 | 16819597 | ||
| Pubmed | 2.54e-14 | 6 | 191 | 6 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 2.54e-14 | 6 | 191 | 6 | 10588881 | |
| Pubmed | RANGAP1 MYH9 MYH10 NUP107 NSD2 SPTAN1 DDX42 NUMA1 NUP98 NVL NUP205 GSTP1 RBM25 MDN1 CCT5 SYNE2 YLPM1 EIF5B CCAR2 PRKDC PLEC CPSF3 TP53BP1 VCP PCNT | 3.16e-14 | 653 | 191 | 25 | 22586326 | |
| Pubmed | KPNA4 RANGAP1 MYH9 MYH10 NUP107 UACA SPTAN1 DDX42 NUMA1 HNRNPM NUP98 NVL NUP205 RBM25 HNRNPUL2 ANLN YLPM1 EIF5B CTBP1 PRKDC PLEC POTEJ CPSF3 THRAP3 VCP | 4.01e-14 | 660 | 191 | 25 | 32780723 | |
| Pubmed | 1.77e-13 | 7 | 191 | 6 | 35210422 | ||
| Pubmed | 7.03e-13 | 8 | 191 | 6 | 3864153 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH2 MYH3 MYH4 KRT7 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B SPTAN1 HNRNPM MDN1 CCT5 TAX1BP1 UGDH CCAR2 PRKDC PLEC TP53BP1 VCP | 1.65e-12 | 647 | 191 | 23 | 26618866 |
| Pubmed | KPNA4 IFT140 MYH9 MYH10 MYH11 KRT14 SPTAN1 CNTRL CEP290 HNRNPM NUP98 DAXX ARAF FBXO30 ASAP2 CEP250 PRKDC PLEC PIBF1 CUX1 | 3.71e-12 | 486 | 191 | 20 | 20936779 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 4.74e-12 | 5 | 191 | 5 | 12919077 | |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 4.74e-12 | 5 | 191 | 5 | 3829126 | |
| Pubmed | 4.74e-12 | 5 | 191 | 5 | 6196357 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 2.83e-11 | 6 | 191 | 5 | 10077619 | |
| Pubmed | RANGAP1 MYH9 MYH10 UACA SPTAN1 HNRNPM RNF14 HNRNPUL2 GLDC CCAR2 PLEC PAN3 CPSF3 THRAP3 VCP | 3.95e-11 | 274 | 191 | 15 | 34244482 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 4.21e-11 | 13 | 191 | 6 | 8404542 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RANGAP1 MYH9 MYH10 KRT14 CAND1 EP400 MAP2 NSD2 SPTAN1 DDX42 HNRNPM SRCAP CCDC61 NUP205 RBM25 HNRNPUL2 YLPM1 IQSEC1 EIF5B INTS4 CTBP1 PRKDC PLEC PAN3 CPSF3 THRAP3 VCP | 5.90e-11 | 1082 | 191 | 27 | 38697112 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EME1 RANGAP1 ZNF148 EP400 UACA SPTAN1 NUMA1 NUP98 DAXX USP19 RBM25 MDN1 ANLN YLPM1 IQSEC1 EIF5B CCAR2 PRKDC PLEC THRAP3 TP53BP1 ALPI ANKS1A | 5.99e-11 | 774 | 191 | 23 | 15302935 |
| Pubmed | MYH9 KRT14 CAND1 EP400 NUP107 IQGAP2 CNTRL HNRNPM NUP98 MAGEC3 DNAH7 USP19 GSTP1 FAT1 BRCA1 CCT5 PI4KB UGDH CCAR2 CTBP1 PRKDC THRAP3 CUX1 | 6.46e-11 | 777 | 191 | 23 | 35844135 | |
| Pubmed | 7.34e-11 | 14 | 191 | 6 | 27184118 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RANGAP1 KRT14 CAND1 EP400 NUP107 CEP290 DDX42 NUMA1 NUP98 SRCAP NUP205 GSTP1 RBM25 MDN1 STXBP2 CCT5 HNRNPUL2 SYNE2 YLPM1 EIF5B CCAR2 PRKDC PLEC THRAP3 VCP PCNT | 9.52e-11 | 1024 | 191 | 26 | 24711643 |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 9.87e-11 | 7 | 191 | 5 | 29758057 | |
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 1.94e-10 | 16 | 191 | 6 | 19922871 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | MYH9 MYH10 CAND1 UACA MYH7B SPTAN1 HNRNPM NUP205 RBM25 UGDH PRKDC PLEC THRAP3 VCP | 3.33e-10 | 268 | 191 | 14 | 33024031 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANGAP1 MYH9 MYH10 CCDC22 CAND1 EP400 NUP107 SPTAN1 NUMA1 HNRNPM SRCAP NCAPG2 NUP205 GSTP1 MDN1 PSME4 CCT5 HNRNPUL2 ANLN UGDH IQSEC1 EIF5B CCAR2 PRKDC PLEC CPSF3 THRAP3 TP53BP1 VCP | 3.79e-10 | 1353 | 191 | 29 | 29467282 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SIN3B RANGAP1 MYH9 MYH10 CAND1 ZNF148 EP400 NUP107 DDX42 NUMA1 HNRNPM NUP98 NUDCD3 CALML5 SRCAP ALDH1A2 YLPM1 EIF5B PRKDC CPSF3 TP53BP1 VCP PCNT ANKS1A | 4.21e-10 | 934 | 191 | 24 | 33916271 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | RANGAP1 EP400 NUP107 SPTAN1 NUMA1 HNRNPM DAXX SRCAP MDN1 CCT5 ANLN CCAR2 PRKDC PLEC TP53BP1 | 5.72e-10 | 332 | 191 | 15 | 32786267 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | KIF13B RANGAP1 MYH10 ZNF148 EP400 NUP107 DDX42 SRCAP NUP205 TAOK2 YLPM1 UGDH EIF5B THRAP3 TP53BP1 | 8.26e-10 | 341 | 191 | 15 | 32971831 |
| Pubmed | 8.81e-10 | 4 | 191 | 4 | 20357587 | ||
| Pubmed | 8.81e-10 | 4 | 191 | 4 | 1985022 | ||
| Pubmed | 8.81e-10 | 4 | 191 | 4 | 19948655 | ||
| Pubmed | 8.81e-10 | 4 | 191 | 4 | 8482409 | ||
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | MYH3 MYH7 MYH8 MYH11 IQGAP2 SPTAN1 NUP98 ZWINT VPS13D ASAP2 HNRNPUL2 VCP | 1.11e-09 | 197 | 191 | 12 | 29872149 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYH4 KRT7 MYH9 MYH10 MYH11 KRT14 NUP107 UACA NUMA1 EIF5B PRKDC PLEC | 1.48e-09 | 202 | 191 | 12 | 33005030 |
| Pubmed | MYH9 MYH10 MYH11 NUMA1 NUP205 RBM25 KRT75 YLPM1 EIF5B PRKDC POTEJ THRAP3 | 1.48e-09 | 202 | 191 | 12 | 24639526 | |
| Pubmed | MYH2 MYH9 NUP107 MYH7B SPTAN1 DDX42 HNRNPM NUP98 NUP205 BRCA1 EIF5B POLQ TP53BP1 | 1.54e-09 | 250 | 191 | 13 | 33536335 | |
| Pubmed | 1.76e-09 | 22 | 191 | 6 | 24301466 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 2.13e-09 | 11 | 191 | 5 | 16024798 | |
| Pubmed | KPNA4 MYH9 MYH10 EP400 SPTAN1 NUMA1 HNRNPM SRCAP FBXO30 RBM25 CCT5 ANLN YLPM1 POTEJ THRAP3 TP53BP1 VCP | 3.55e-09 | 506 | 191 | 17 | 30890647 | |
| Pubmed | 3.64e-09 | 12 | 191 | 5 | 8424456 | ||
| Pubmed | KPNA4 RANGAP1 MYH10 URI1 KRT14 CCDC22 NUP107 NSD2 SPTAN1 CEP290 NUP98 PPM1M NUDCD3 CCDC61 KIF15 CCT5 SYNE2 YLPM1 INTS4 CCAR2 PIBF1 SLC12A7 CPSF3 PCNT | 4.11e-09 | 1049 | 191 | 24 | 27880917 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RANGAP1 MYH9 CAND1 NUP107 SPTAN1 DDX42 HNRNPM RNF17 SSUH2 MDN1 CCT5 ANLN YLPM1 PRKDC PLEC CPSF3 THRAP3 PCNT | 4.39e-09 | 582 | 191 | 18 | 20467437 |
| Pubmed | 5.89e-09 | 13 | 191 | 5 | 8948582 | ||
| Pubmed | MYH10 KRT14 NUP107 HNRNPM NUP98 NUP205 RBM25 MDN1 HNRNPUL2 CEP250 PRKDC PLEC THRAP3 PCNT | 7.13e-09 | 340 | 191 | 14 | 29478914 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | KPNA4 MYH9 CCDC22 UACA NSD2 CNTRL CEP290 NUP98 NVL ZWINT MIPOL1 ATP2C1 MDN1 CEP250 PDE4DIP INTS4 PIBF1 CPSF3 CUX1 PCNT | 7.84e-09 | 754 | 191 | 20 | 33060197 |
| Pubmed | 9.12e-09 | 14 | 191 | 5 | 24938781 | ||
| Pubmed | 1.00e-08 | 191 | 191 | 11 | 33762435 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | KPNA4 MYH2 MYH4 MYH7 RANGAP1 MYH9 MYH10 IQGAP2 HNRNPM NUP98 IRGQ CALML5 ARAF NUP205 ASAP2 RBM25 LOXHD1 PI4KB CCAR2 POLQ PDCD10 THRAP3 TCEAL9 VCP ALPI ANKS1A | 1.08e-08 | 1284 | 191 | 26 | 17353931 |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | KRT7 MYH9 KRT14 HNRNPM CALML5 RBM25 CCT5 UGDH IQSEC1 CARD6 PLEC CPSF3 THRAP3 VCP | 1.14e-08 | 353 | 191 | 14 | 27545878 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RANGAP1 MYH10 CCDC22 CNTRL CEP290 CFI DNAH7 ARAF NUP205 MIPOL1 SH3PXD2B ALDH1A2 STXBP2 CCT5 CEP250 PLEC PAN3 PIBF1 CEP170B PCNT ANKS1A | 1.18e-08 | 853 | 191 | 21 | 28718761 |
| Pubmed | SIN3B RANGAP1 CCDC22 ZNF148 EP400 SPTAN1 NUMA1 SRCAP SH3PXD2B RBM25 CCT5 ANLN YLPM1 PRKDC THRAP3 CUX1 TP53BP1 | 1.18e-08 | 549 | 191 | 17 | 38280479 | |
| Pubmed | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas. | KPNA4 RANGAP1 KRT14 NUP107 NUP98 NUP205 CTBP1 PRKDC THRAP3 VCP | 1.35e-08 | 152 | 191 | 10 | 28192407 |
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 1.36e-08 | 15 | 191 | 5 | 24852826 | |
| Pubmed | MYH2 MYH4 KRT7 MYH7 MYH9 MYH10 KRT14 SPTAN1 RBM25 UGDH PRKDC PLEC POTEJ | 1.66e-08 | 305 | 191 | 13 | 33194618 | |
| Pubmed | 1.67e-08 | 31 | 191 | 6 | 21985497 | ||
| Pubmed | RANGAP1 MYH9 MYH10 CAND1 NUP107 SPTAN1 NUMA1 HNRNPM BRCA1 CCT5 HNRNPUL2 EIF5B CCAR2 PLEC TP53BP1 VCP | 1.74e-08 | 494 | 191 | 16 | 26831064 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT7 MYH9 MYH10 KRT14 EP400 MAP2 SPTAN1 CNTRL CEP290 HNRNPM NUP205 VPS13D PSME4 PRKDC PLEC THRAP3 MYBPC2 | 1.75e-08 | 564 | 191 | 17 | 21565611 |
| Pubmed | Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A. | 1.80e-08 | 82 | 191 | 8 | 30274258 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | SIN3B KRT7 RANGAP1 MYH9 SPTAN1 DDX42 NUP98 KIF15 ANLN EIF5B PRKDC PLEC | 2.11e-08 | 256 | 191 | 12 | 33397691 |
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 2.48e-08 | 33 | 191 | 6 | 32094117 | |
| Pubmed | 2.78e-08 | 17 | 191 | 5 | 16124007 | ||
| Pubmed | 3.05e-08 | 7 | 191 | 4 | 21126233 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MYH9 MYH10 MIS18A DDX42 NUMA1 HNRNPM DAXX CALML5 NUP205 GSTP1 RBM25 MDN1 CCT5 ANLN YLPM1 CCAR2 PRKDC PLEC CPSF3 THRAP3 TP53BP1 VCP | 3.14e-08 | 989 | 191 | 22 | 36424410 |
| Pubmed | 3.20e-08 | 58 | 191 | 7 | 21884692 | ||
| Pubmed | RANGAP1 URI1 CAND1 SPTAN1 DDX42 NUMA1 HNRNPM SRCAP CCT5 HNRNPUL2 ANLN ACTR6 INTS4 CCAR2 | 3.97e-08 | 390 | 191 | 14 | 17643375 | |
| Pubmed | MYH9 CAND1 EP400 NSD2 DDX42 NUMA1 NUP98 NVL NUP205 GSTP1 RBM25 MDN1 CCT5 HNRNPUL2 YLPM1 EIF5B CCAR2 PRKDC PLEC CPSF3 THRAP3 VCP | 4.87e-08 | 1014 | 191 | 22 | 32416067 | |
| Pubmed | KPNA4 CAND1 ZNF148 EP400 NUP107 CEP290 NUMA1 NUP98 NUP205 INTS4 CCAR2 CTBP1 HYDIN TP53BP1 ANKS1A | 5.83e-08 | 469 | 191 | 15 | 27634302 | |
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 6.06e-08 | 8 | 191 | 4 | 14667415 | |
| Pubmed | 6.06e-08 | 8 | 191 | 4 | 26993635 | ||
| Pubmed | KPNA4 MYH9 KRT14 SPTAN1 NUMA1 HNRNPM RSPH3 ASAP2 KRT75 PLEC THRAP3 PCNT | 6.59e-08 | 284 | 191 | 12 | 29459677 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | MYH9 MYH10 SPTAN1 NUMA1 HNRNPM CALML5 ARAF RBM25 CCT5 EIF5B PRKDC PLEC THRAP3 CUX1 VCP | 7.26e-08 | 477 | 191 | 15 | 31300519 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MYH9 MYH10 CAND1 ZNF148 EP400 MIS18A NUMA1 HNRNPM NUP98 AK6 NUP205 RBM25 MDN1 STXBP2 CCT5 HNRNPUL2 IQSEC1 EIF5B PRKCB CCAR2 CTBP1 PRKDC PLEC CPSF3 THRAP3 | 7.46e-08 | 1318 | 191 | 25 | 30463901 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | MYH2 MYH7 MYH9 MYH10 PDE4A KRT14 UACA IQGAP2 SPTAN1 NUMA1 HNRNPM TAX1BP1 PRKDC PLEC THRAP3 CUX1 VCP | 7.88e-08 | 626 | 191 | 17 | 33644029 |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | KPNA4 SIN3B HJURP NUP98 MDN1 CCT5 SYNE2 YLPM1 CCAR2 CTBP1 PRKDC THRAP3 | 7.97e-08 | 289 | 191 | 12 | 23752268 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | MYH9 MYH10 MYH11 CAND1 SPTAN1 VPS13D ASAP2 PRKDC PLEC THRAP3 TP53BP1 | 8.42e-08 | 235 | 191 | 11 | 30258100 |
| Pubmed | RANGAP1 MYH9 MYH10 MAP2 SPTAN1 HNRNPM KCNB2 ZWINT TAOK2 STX1A ATP2C1 CCT5 CAMKV HNRNPUL2 PDE4DIP IQSEC1 PRKCB PLEC THRAP3 CEP170B GABBR1 TP53BP1 VCP | 8.60e-08 | 1139 | 191 | 23 | 36417873 | |
| Pubmed | SIN3B HNF1B MYH10 ZNF148 EP400 NUP107 SPTAN1 NUMA1 NUP98 CALML5 SRCAP NUP205 FAT1 RBM25 BRCA1 CCT5 HNRNPUL2 TTC31 ACTR6 SYNE2 YLPM1 CCAR2 CTBP1 PAN3 CUX1 TP53BP1 | 9.04e-08 | 1429 | 191 | 26 | 35140242 | |
| Pubmed | 9.33e-08 | 101 | 191 | 8 | 26949739 | ||
| Pubmed | RANGAP1 MYH10 CAND1 NUP107 SPTAN1 HNRNPM NUP98 USP19 NUP205 MDN1 CCT5 EIF5B CCAR2 PRKDC PLEC CPSF3 VCP | 1.03e-07 | 638 | 191 | 17 | 33239621 | |
| Pubmed | MYH2 RANGAP1 MYH10 CCDC22 CAND1 UACA IQGAP2 SPTAN1 NUMA1 AK6 CALML5 NCAPG2 NUP205 GSTP1 MDN1 CCT5 HNRNPUL2 SYNE2 EIF5B CCAR2 CTBP1 PRKDC THRAP3 CUX1 VCP ALPI | 1.05e-07 | 1440 | 191 | 26 | 30833792 | |
| Pubmed | KPNA4 HNF1B RANGAP1 MYH9 MYH10 CAND1 NUP107 UACA SPTAN1 NUMA1 HNRNPM NUP98 ARAF GSTP1 RBM25 CCT5 TAX1BP1 UGDH EIF5B CTBP1 PRKDC THRAP3 CUX1 VCP | 1.07e-07 | 1247 | 191 | 24 | 27684187 | |
| Pubmed | 1.09e-07 | 9 | 191 | 4 | 31960486 | ||
| Pubmed | 1.16e-07 | 22 | 191 | 5 | 37468485 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | KPNA4 SIN3B MYH9 URI1 UACA NUMA1 HNRNPM ZWINT BRCA1 ANLN PLEC THRAP3 VCP | 1.19e-07 | 361 | 191 | 13 | 30344098 |
| Pubmed | EME1 CCDC22 EP400 NSD2 SPTAN1 CEP290 SRCAP CCDC61 BRCA1 ANLN ACTR6 TAX1BP1 CTBP1 PIBF1 CPSF3 THRAP3 PCNT | 1.20e-07 | 645 | 191 | 17 | 25281560 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | KPNA4 RANGAP1 MYH9 MYH10 NUP107 IQGAP2 MAP2 DDX42 NUMA1 SH3PXD2B SYNE2 UGDH EIF5B CTBP1 ANKS1A | 1.26e-07 | 498 | 191 | 15 | 36634849 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | KPNA4 EP400 HJURP NUMA1 HNRNPM NUP98 APOBR NBPF20 MAP3K1 ASAP2 YLPM1 IGSF9B PLEC PCNT | 1.32e-07 | 430 | 191 | 14 | 35044719 |
| Pubmed | 1.46e-07 | 107 | 191 | 8 | 32989256 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CACNA1F MYH1 SIN3B MYH3 MYH4 RANGAP1 MYH9 CEP290 NTMT1 HNRNPM TSPYL6 NUP205 MIPOL1 LOXHD1 MDN1 PRKCB IGSF9B PRKDC | 1.53e-07 | 736 | 191 | 18 | 29676528 |
| Pubmed | MYH2 MYH4 CAND1 IQGAP2 NUDCD3 IRGQ ZWINT NUP205 PI4KB YLPM1 EIF5B CCAR2 PRKDC CEP170B | 1.60e-07 | 437 | 191 | 14 | 20562859 | |
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 8620598 | ||
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 25567808 | ||
| Pubmed | Identification of three developmentally controlled isoforms of human myosin heavy chains. | 1.63e-07 | 3 | 191 | 3 | 1691980 | |
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 21470888 | ||
| Pubmed | Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. | 1.63e-07 | 3 | 191 | 3 | 1939265 | |
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 30352856 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 1.63e-07 | 3 | 191 | 3 | 26059207 | |
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 36515178 | ||
| Pubmed | Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. | 1.63e-07 | 3 | 191 | 3 | 1694848 | |
| Interaction | AURKC interactions | 1.81e-10 | 43 | 187 | 9 | int:AURKC | |
| Interaction | HDAC1 interactions | KPNA4 MYH1 MYH2 SIN3B MYH4 HNF1B MYH7 MYH8 MYH9 MYH10 ZNF148 EP400 NUP107 NSD2 SPTAN1 HNRNPM NUP98 DAXX ARAF USP19 RBM25 BRCA1 KIF15 CCT5 ANLN CEP250 TAX1BP1 SYNE2 CCAR2 CTBP1 PLEC CUX1 PCNT | 2.50e-09 | 1108 | 187 | 33 | int:HDAC1 |
| Interaction | EED interactions | KPNA4 RANGAP1 MYH9 MYH10 MYH11 CAND1 EP400 NUP107 NSD2 TRIM35 SPTAN1 CEP290 HJURP DDX42 NUMA1 HNRNPM NUP98 NVL NUP205 RBM25 STXBP2 BRCA1 CCT5 HNRNPUL2 GLDC ANLN YLPM1 EIF5B CCAR2 CTBP1 PRKDC PLEC CPSF3 THRAP3 CEP170B TP53BP1 VCP PCNT | 4.03e-09 | 1445 | 187 | 38 | int:EED |
| Interaction | NUPR1 interactions | KPNA4 RANGAP1 MYH9 MYH10 NUP107 UACA SPTAN1 DDX42 NUMA1 HNRNPM NUP98 NVL NUP205 RBM25 HNRNPUL2 ANLN YLPM1 EIF5B CTBP1 PRKDC PLEC POTEJ CPSF3 THRAP3 VCP | 4.96e-09 | 683 | 187 | 25 | int:NUPR1 |
| Interaction | SIRT7 interactions | RANGAP1 MYH9 MYH10 NUP107 NSD2 SPTAN1 DDX42 NUMA1 NUP98 NVL NUP205 GSTP1 RBM25 MDN1 CCT5 SYNE2 YLPM1 EIF5B CCAR2 PRKDC PLEC CPSF3 TP53BP1 VCP PCNT | 2.69e-08 | 744 | 187 | 25 | int:SIRT7 |
| Interaction | AR interactions | SIN3B DCAF6 MYH10 CAND1 ZNF148 EP400 NSD2 DDX42 NUMA1 HNRNPM NVL DAXX SRCAP RNF14 RBM25 MDN1 BRCA1 KIF15 HNRNPUL2 ANLN TAX1BP1 YLPM1 INTS4 CCAR2 CTBP1 PRKDC THRAP3 CUX1 VCP | 3.97e-08 | 992 | 187 | 29 | int:AR |
| Interaction | NPHP4 interactions | KRT7 MYH9 MYH10 KRT14 EP400 SPTAN1 CNTRL NUDCD3 NUP205 VPS13D PRKDC PLEC THRAP3 MYBPC2 | 4.60e-08 | 236 | 187 | 14 | int:NPHP4 |
| Interaction | SLFN11 interactions | MYH2 MYH9 MYH10 MYH11 NUP107 MYH7B SPTAN1 DDX42 HNRNPM NUP98 NUP205 BRCA1 CCT5 EIF5B POLQ TP53BP1 VCP | 8.71e-08 | 376 | 187 | 17 | int:SLFN11 |
| Interaction | MECP2 interactions | KPNA4 SIN3B RANGAP1 MYH9 MYH10 KRT14 CAND1 EP400 MAP2 NSD2 SPTAN1 DDX42 HNRNPM NVL SRCAP CCDC61 KLHL20 NUP205 RBM25 HNRNPUL2 ANLN YLPM1 IQSEC1 EIF5B INTS4 CTBP1 PRKDC PLEC PAN3 CPSF3 THRAP3 TP53BP1 VCP | 9.24e-08 | 1287 | 187 | 33 | int:MECP2 |
| Interaction | FKBP6 interactions | 1.05e-07 | 86 | 187 | 9 | int:FKBP6 | |
| Interaction | ASAH2 interactions | 1.06e-07 | 6 | 187 | 4 | int:ASAH2 | |
| Interaction | PLEC interactions | MYH9 KRT14 MAP2 NSD2 SPTAN1 HNRNPM ARHGEF25 BRCA1 GLDC ANLN SYNE2 PDE4DIP CCAR2 PLEC DNAH5 THRAP3 VCP PCNT | 1.14e-07 | 430 | 187 | 18 | int:PLEC |
| Interaction | HIF1A interactions | KPNA4 MYH1 MYH2 MYH3 MYH4 MYH6 CAND1 EP400 UACA HNRNPM FBXO30 USP19 CITED2 FAT1 BRCA1 CCAR2 PRKDC VCP | 1.65e-07 | 441 | 187 | 18 | int:HIF1A |
| Interaction | GLDC interactions | RANGAP1 MYH9 MYH10 UACA SPTAN1 HNRNPM RNF14 HNRNPUL2 GLDC CCAR2 PLEC PAN3 CPSF3 THRAP3 VCP | 3.40e-07 | 321 | 187 | 15 | int:GLDC |
| Interaction | MAPRE1 interactions | KPNA4 RANGAP1 NUP107 MAP2 SPTAN1 CEP290 NUMA1 NUP98 NUP205 TAOK2 HNRNPUL2 CEP250 PDE4DIP EIF5B PLEC PIBF1 GOLGA1 CEP170B PCNT | 3.40e-07 | 514 | 187 | 19 | int:MAPRE1 |
| Interaction | MDC1 interactions | SIN3B DCAF6 ZNF148 NSD2 NUMA1 KLHL20 CENPP BRCA1 HNRNPUL2 ANLN TAX1BP1 ATXN3 CTBP1 PRKDC CPSF3 THRAP3 TP53BP1 | 3.41e-07 | 414 | 187 | 17 | int:MDC1 |
| Interaction | DNAH5 interactions | 3.58e-07 | 31 | 187 | 6 | int:DNAH5 | |
| Interaction | LRRC31 interactions | MYH4 KRT7 MYH9 MYH10 MYH11 KRT14 NUP107 UACA NUMA1 EIF5B PRKDC PLEC | 4.99e-07 | 205 | 187 | 12 | int:LRRC31 |
| Interaction | RSPH6A interactions | 6.38e-07 | 34 | 187 | 6 | int:RSPH6A | |
| Interaction | SUMO2 interactions | EME1 HNF1B RANGAP1 EP400 NUP107 SPTAN1 NUMA1 HNRNPM DAXX SRCAP MDN1 BRCA1 CCT5 ANLN CCAR2 PRKDC PLEC CUX1 TP53BP1 VCP | 6.60e-07 | 591 | 187 | 20 | int:SUMO2 |
| Interaction | CFTR interactions | MYH1 MYH2 MYH3 MYH4 KRT7 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 KRT14 CAND1 MYH7B SPTAN1 HNRNPM MAGEC3 CALML5 USP19 STX1A RBM25 MDN1 KRT75 CCT5 CAMKV ANLN TAX1BP1 UGDH CCAR2 PRKDC PLEC SLC9A6 TP53BP1 VCP | 7.47e-07 | 1480 | 187 | 34 | int:CFTR |
| Interaction | OBSL1 interactions | RANGAP1 KRT14 EP400 NUP107 MAP2 DDX42 NUMA1 NUP98 DAXX SRCAP NUP205 RBM25 MDN1 CCT5 HNRNPUL2 SYNE2 YLPM1 EIF5B CCAR2 PRKDC PLEC POLQ THRAP3 VCP PCNT | 1.01e-06 | 902 | 187 | 25 | int:OBSL1 |
| Interaction | MEN1 interactions | KIF13B RANGAP1 MYH9 MYH10 ZNF148 EP400 NUP107 DDX42 NUMA1 HNRNPM NUP98 NVL DAXX SRCAP NUP205 TAOK2 RBM25 MDN1 ANLN YLPM1 UGDH EIF5B CPSF3 THRAP3 CUX1 TP53BP1 VCP | 1.03e-06 | 1029 | 187 | 27 | int:MEN1 |
| Interaction | YAP1 interactions | SIN3B HNF1B RANGAP1 MYH9 MYH10 MYH11 KRT14 CCDC22 CAND1 ZNF148 UACA MAP2 SPTAN1 NUMA1 HNRNPM SRCAP RBM25 KRT75 CCT5 YLPM1 ATXN3 IGSF9B PRKDC PLEC POTEJ THRAP3 CUX1 VCP | 1.05e-06 | 1095 | 187 | 28 | int:YAP1 |
| Interaction | HERC2 interactions | EME1 MYH10 URI1 CCDC22 CEP290 FHOD3 ARAF USP19 FBXL5 RBM25 BRCA1 KIF15 CEP250 SYNE2 EIF5B PLEC CUX1 TP53BP1 | 1.12e-06 | 503 | 187 | 18 | int:HERC2 |
| Interaction | AGRN interactions | MYH3 MYH7 MYH8 MYH11 IQGAP2 SPTAN1 NUP98 ZWINT VPS13D ASAP2 CAMKV HNRNPUL2 VCP | 1.34e-06 | 267 | 187 | 13 | int:AGRN |
| Interaction | DDX39B interactions | KRT7 MYH9 MYH10 KRT14 SPTAN1 HNRNPM CALML5 GSTP1 RBM25 BRCA1 CCT5 HNRNPUL2 GLDC ANLN IQSEC1 PRKDC PLEC THRAP3 TP53BP1 | 1.60e-06 | 570 | 187 | 19 | int:DDX39B |
| Interaction | PPP1R9B interactions | MYH4 MYH9 MYH10 MYH11 CAND1 MAP2 SPTAN1 ARHGEF25 TAOK2 BRCA1 CCT5 CAMKV HNRNPUL2 GLDC ANLN IQSEC1 PRKCB PLEC GOLGA1 VCP | 1.60e-06 | 626 | 187 | 20 | int:PPP1R9B |
| Interaction | SLX4 interactions | EME1 RANGAP1 CAND1 EP400 NUMA1 HNRNPM NVL DAXX CALML5 NCAPG2 MDN1 BRCA1 CCT5 IQSEC1 CCAR2 PRKDC POLQ TP53BP1 VCP | 1.68e-06 | 572 | 187 | 19 | int:SLX4 |
| Interaction | SIRT6 interactions | MYH7 EP400 NUP107 NUMA1 HNRNPM NUP98 NVL DAXX SRCAP NUP205 FAT1 CCT5 HNRNPUL2 ACTR6 YLPM1 CCAR2 PRKDC EIF2AK3 TP53BP1 ANKS1A | 1.68e-06 | 628 | 187 | 20 | int:SIRT6 |
| Interaction | NUP62 interactions | CCDC22 NUP107 NUMA1 NUP98 NUP205 KRT75 ANLN CEP250 SYNE2 CTBP1 CUX1 VCP PCNT | 1.71e-06 | 273 | 187 | 13 | int:NUP62 |
| Interaction | ACTR1A interactions | KPNA4 MYH9 MYH10 MIS18A NUMA1 NUDCD3 RBM25 CCT5 ANLN ATXN3 PLEC CEP170B VCP | 1.79e-06 | 274 | 187 | 13 | int:ACTR1A |
| Interaction | RUVBL1 interactions | HNF1B MYH9 MYH10 URI1 CAND1 EP400 HJURP DDX42 NUMA1 SRCAP ARAF BRCA1 ANLN ACTR6 CEP250 ATXN3 PRKDC TP53BP1 VCP | 1.81e-06 | 575 | 187 | 19 | int:RUVBL1 |
| Interaction | FUS interactions | MYH10 CAND1 UACA DDX42 NUMA1 HNRNPM NCAPG2 ARAF GSTP1 RBM25 BRCA1 CCT5 HNRNPUL2 GLDC ANLN YLPM1 INTS4 CCAR2 PRKDC THRAP3 TP53BP1 VCP | 2.22e-06 | 757 | 187 | 22 | int:FUS |
| Interaction | TSPAN33 interactions | 2.34e-06 | 65 | 187 | 7 | int:TSPAN33 | |
| Interaction | UBE2I interactions | KPNA4 RANGAP1 MYH9 NUP107 NUMA1 HNRNPM NUP98 NVL DAXX NUDCD3 MAP3K1 NUP205 MIPOL1 STX1A RBM25 BRCA1 CTBP1 PRKDC GOLGA1 TP53BP1 | 3.11e-06 | 654 | 187 | 20 | int:UBE2I |
| Interaction | PRKAG2 interactions | 3.18e-06 | 68 | 187 | 7 | int:PRKAG2 | |
| Interaction | KPNB1 interactions | KPNA4 RANGAP1 CAND1 NUP107 NUMA1 NUP98 ARAF NUP205 BRCA1 HNRNPUL2 RAPGEF3 GLDC ANLN PNMA8A ATXN3 THRAP3 TP53BP1 VCP | 3.38e-06 | 544 | 187 | 18 | int:KPNB1 |
| Interaction | KRT8 interactions | MYH1 KRT7 MYH9 KRT14 CCDC22 NUP107 UACA NUP205 KRT75 KIF15 ANLN PLEC PIBF1 CUX1 VCP PCNT | 3.81e-06 | 441 | 187 | 16 | int:KRT8 |
| Interaction | FGD5 interactions | 3.86e-06 | 207 | 187 | 11 | int:FGD5 | |
| Interaction | SLC39A3 interactions | 3.87e-06 | 70 | 187 | 7 | int:SLC39A3 | |
| Interaction | DCPS interactions | MYH10 KRT14 NUP107 HNRNPM NUP98 NUP205 RBM25 MDN1 HNRNPUL2 CEP250 PRKDC PLEC PDCD10 THRAP3 PCNT | 4.34e-06 | 394 | 187 | 15 | int:DCPS |
| Interaction | ITGB3 interactions | 4.38e-06 | 170 | 187 | 10 | int:ITGB3 | |
| Interaction | GAN interactions | KRT14 SPTAN1 HNRNPM NUDCD3 KRT75 CCT5 ANLN SYNE2 PLEC THRAP3 CUX1 PCNT | 4.52e-06 | 253 | 187 | 12 | int:GAN |
| Interaction | YWHAZ interactions | KIF13B MYH9 MYH10 MYH11 NUP107 UACA MAP2 SPTAN1 HJURP ARAF MAP3K1 GSTP1 VPS13D MCTP1 BRCA1 KIF15 CAMKV ANLN PI4KB TAX1BP1 SYNE2 CCAR2 PLEC CEP170B GABBR1 TP53BP1 VCP PCNT IL9R ANKS1A | 4.53e-06 | 1319 | 187 | 30 | int:YWHAZ |
| Interaction | ACTN2 interactions | 4.61e-06 | 171 | 187 | 10 | int:ACTN2 | |
| Interaction | TMEM260 interactions | 4.81e-06 | 13 | 187 | 4 | int:TMEM260 | |
| Interaction | HSPB8 interactions | 4.86e-06 | 172 | 187 | 10 | int:HSPB8 | |
| Interaction | MKS1 interactions | 6.11e-06 | 139 | 187 | 9 | int:MKS1 | |
| Interaction | LGR4 interactions | MYH9 MYH10 MYH11 NUMA1 NUP205 RBM25 KRT75 YLPM1 EIF5B PRKDC POTEJ THRAP3 | 6.45e-06 | 262 | 187 | 12 | int:LGR4 |
| Interaction | MECOM interactions | MYH1 MYH2 MYH4 MYH7 MYH8 ZNF148 NUP205 HNRNPUL2 CTBP1 PRKDC PLEC CCDC180 TP53BP1 MYBPC2 | 6.74e-06 | 358 | 187 | 14 | int:MECOM |
| Interaction | TRIM37 interactions | MYH2 MYH4 KRT7 HNF1B MYH7 MYH9 MYH10 KRT14 SPTAN1 RBM25 APEX2 CEP250 UGDH CCAR2 PRKDC PLEC POTEJ PIBF1 CEP170B | 6.79e-06 | 630 | 187 | 19 | int:TRIM37 |
| Interaction | NKX2-1 interactions | KPNA4 RANGAP1 KRT14 NUP107 NUP98 NUP205 CTBP1 PRKDC THRAP3 VCP | 7.27e-06 | 180 | 187 | 10 | int:NKX2-1 |
| Interaction | NDC80 interactions | CCDC22 UACA CEP290 DDX42 CCDC61 ZWINT KRT75 KIF15 CEP250 SYNE2 PIBF1 CEP170B PCNT | 7.37e-06 | 312 | 187 | 13 | int:NDC80 |
| Interaction | RANBP2 interactions | KPNA4 IFT140 RANGAP1 NUP107 NUMA1 HNRNPM NUP98 DAXX NUP205 TAOK2 RAPGEF3 PRKDC VCP MYBPC2 | 7.41e-06 | 361 | 187 | 14 | int:RANBP2 |
| Interaction | SPDL1 interactions | MYH9 MYH10 MYH11 CAND1 SPTAN1 ZWINT VPS13D ASAP2 YLPM1 PRKDC PLEC THRAP3 TP53BP1 | 8.17e-06 | 315 | 187 | 13 | int:SPDL1 |
| Interaction | NUMA1 interactions | RANGAP1 MYH10 NUP107 NSD2 NUMA1 NUP98 SRCAP NUP205 KRT75 BRCA1 ANLN TAX1BP1 ARHGAP44 EIF5B TP53BP1 VCP | 8.28e-06 | 469 | 187 | 16 | int:NUMA1 |
| Interaction | MYH8 interactions | 8.41e-06 | 52 | 187 | 6 | int:MYH8 | |
| Interaction | ENO1 interactions | MYH7 RANGAP1 MYH9 MYH10 MYH11 CAND1 NSD2 NUMA1 HNRNPM ARAF NUP205 GSTP1 RBM25 BRCA1 ANLN CEP250 ATXN3 EIF5B TP53BP1 VCP | 8.71e-06 | 701 | 187 | 20 | int:ENO1 |
| Interaction | NEFM interactions | 1.17e-05 | 190 | 187 | 10 | int:NEFM | |
| Interaction | YWHAG interactions | KIF13B MYH10 UACA MAP2 SPTAN1 HJURP HNRNPM DNAH7 ARAF MAP3K1 TAOK2 VPS13D MDN1 KIF15 ANLN PI4KB CEP250 SYNE2 IQSEC1 PRKCB PRKDC PAN3 PIBF1 CPSF3 THRAP3 CEP170B VCP ANKS1A | 1.26e-05 | 1248 | 187 | 28 | int:YWHAG |
| Interaction | TPTE2 interactions | 1.31e-05 | 84 | 187 | 7 | int:TPTE2 | |
| Interaction | NAA40 interactions | SIN3B RANGAP1 MYH9 MYH10 CAND1 ZNF148 EP400 NUP107 DDX42 NUMA1 HNRNPM NUP98 NUDCD3 CALML5 SRCAP ALDH1A2 YLPM1 EIF5B PRKDC CPSF3 TP53BP1 VCP PCNT ANKS1A | 1.33e-05 | 978 | 187 | 24 | int:NAA40 |
| Interaction | TNIK interactions | SPTAN1 TAOK2 CAMKV PI4KB SYNE2 PDE4DIP IQSEC1 DCHS1 PRKCB CCAR2 CTBP1 THRAP3 CEP170B TP53BP1 | 1.36e-05 | 381 | 187 | 14 | int:TNIK |
| Interaction | GRIN1 interactions | 1.40e-05 | 154 | 187 | 9 | int:GRIN1 | |
| Interaction | YWHAQ interactions | KIF13B MYH2 MYH7 MYH9 MYH11 NUP107 UACA MAP2 HJURP NUMA1 CALML5 DNAH7 ARAF MAP3K1 VPS13D BRCA1 ANLN PI4KB CEP250 CCAR2 PRKDC PLEC PAN3 CEP170B VCP ANKS1A | 1.44e-05 | 1118 | 187 | 26 | int:YWHAQ |
| Interaction | PHLPP1 interactions | SIN3B KRT7 RANGAP1 MYH9 SPTAN1 DDX42 NUP98 NUDCD3 KIF15 ANLN EIF5B PRKDC PLEC | 1.48e-05 | 333 | 187 | 13 | int:PHLPP1 |
| Interaction | WHAMMP3 interactions | 1.54e-05 | 119 | 187 | 8 | int:WHAMMP3 | |
| Interaction | ISG15 interactions | MYH9 MYH10 CAND1 UACA MYH7B SPTAN1 DDX42 HNRNPM NUP205 GSTP1 RBM25 UGDH PRKDC PLEC THRAP3 VCP | 1.57e-05 | 494 | 187 | 16 | int:ISG15 |
| Interaction | DST interactions | MYH6 MYH9 KRT14 SPTAN1 CEP290 BRCA1 ANLN CEP250 PLEC GOLGA1 PCNT MYBPC2 | 1.61e-05 | 287 | 187 | 12 | int:DST |
| Interaction | BCAP31 interactions | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH7B CEP290 KCNB2 SYNE2 ATXN3 MYH15 EIF2AK3 VCP | 1.70e-05 | 554 | 187 | 17 | int:BCAP31 |
| Interaction | TERF2 interactions | KIF13B EME1 MYH9 MYH10 NUMA1 PRPS1L1 BRCA1 SYNE2 UGDH CTBP1 THRAP3 TP53BP1 VCP | 1.84e-05 | 340 | 187 | 13 | int:TERF2 |
| Interaction | TCOF1 interactions | HNF1B MYH9 MYH10 MYH11 CAND1 NSD2 ARAF BRCA1 CAMKV PI4KB ARHGAP44 THRAP3 | 1.91e-05 | 292 | 187 | 12 | int:TCOF1 |
| Interaction | CDK9 interactions | KRT7 MYH9 MYH10 NUP107 SPTAN1 DDX42 NUMA1 HNRNPM NUP98 SRCAP ARAF NUP205 RBM25 BRCA1 CCT5 ANLN CCAR2 PRKDC PLEC | 2.18e-05 | 685 | 187 | 19 | int:CDK9 |
| Interaction | OFD1 interactions | URI1 CCDC22 MIS18A CNTRL CEP290 NUDCD3 CCDC61 ANLN CTBP1 PIBF1 GOLGA1 CEP170B PCNT | 2.27e-05 | 347 | 187 | 13 | int:OFD1 |
| Interaction | TEDC2 interactions | 2.35e-05 | 206 | 187 | 10 | int:TEDC2 | |
| Interaction | NEK2 interactions | 2.48e-05 | 127 | 187 | 8 | int:NEK2 | |
| Interaction | ZSCAN5A interactions | 2.55e-05 | 38 | 187 | 5 | int:ZSCAN5A | |
| Interaction | NINL interactions | CCDC22 MIS18A CEP290 CALML5 MIPOL1 GSTP1 BRCA1 APEX2 CEP250 CCAR2 PRKDC PAN3 PIBF1 CEP170B PCNT | 2.57e-05 | 458 | 187 | 15 | int:NINL |
| Interaction | ACTC1 interactions | KPNA4 MYH9 MYH10 EP400 SPTAN1 NUMA1 HNRNPM SRCAP FBXO30 RBM25 CCT5 ANLN SYNE2 YLPM1 PLEC POTEJ THRAP3 TP53BP1 VCP | 2.61e-05 | 694 | 187 | 19 | int:ACTC1 |
| Interaction | DEK interactions | KIF13B MYH10 CAND1 DAXX RBM25 KIF15 TAX1BP1 THRAP3 TP53BP1 VCP | 2.66e-05 | 209 | 187 | 10 | int:DEK |
| Interaction | CIT interactions | RANGAP1 MYH9 MYH10 MYH11 EP400 NUP107 SPTAN1 DDX42 NUMA1 HNRNPM NUP98 NVL RAD21L1 NUP205 RBM25 BRCA1 CCT5 HNRNPUL2 ANLN SYNE2 EIF5B INTS4 CCAR2 PRKDC PLEC POTEJ PIBF1 CCDC180 THRAP3 CUX1 | 2.82e-05 | 1450 | 187 | 30 | int:CIT |
| Interaction | ACTA2 interactions | MYH6 MYH9 MYH10 MYH11 CAND1 SPTAN1 CALML5 ARAF FBXO30 GSTP1 CCT5 PLEC POTEJ | 2.88e-05 | 355 | 187 | 13 | int:ACTA2 |
| Interaction | SYNGAP1 interactions | CAND1 IQGAP2 MAP2 KCNB2 TAOK2 ASAP2 CEP250 SYNE2 IQSEC1 TP53BP1 PCNT ANKS1A | 3.13e-05 | 307 | 187 | 12 | int:SYNGAP1 |
| Interaction | KAT5 interactions | KPNA4 RANGAP1 DCAF6 EP400 NSD2 SPTAN1 SRCAP MAP3K1 BRCA1 TAX1BP1 CCAR2 PRKDC IL9R | 3.15e-05 | 358 | 187 | 13 | int:KAT5 |
| Interaction | PARP1 interactions | HNF1B RANGAP1 MYH10 CAND1 ZNF148 EP400 IQGAP2 NSD2 NTMT1 NUMA1 NVL DAXX NUDCD3 SRCAP ARAF ASAP2 RBM25 MDN1 BRCA1 GLDC ANLN ATXN3 CCAR2 PRKDC THRAP3 CUX1 TP53BP1 VCP | 3.30e-05 | 1316 | 187 | 28 | int:PARP1 |
| Interaction | PRC1 interactions | KPNA4 RANGAP1 MYH9 MYH10 NUP107 SPTAN1 NUMA1 HNRNPM NUP98 NVL NUP205 RBM25 BRCA1 CCT5 HNRNPUL2 ANLN EIF5B PRKDC PLEC PAN3 POTEJ THRAP3 VCP | 3.67e-05 | 973 | 187 | 23 | int:PRC1 |
| Interaction | GRIN2D interactions | 3.73e-05 | 41 | 187 | 5 | int:GRIN2D | |
| Interaction | KRT18 interactions | KRT7 URI1 KRT14 CCDC22 CEP290 NUP205 KRT75 BRCA1 KIF15 ANLN PDE4DIP PLEC PIBF1 PCNT | 3.88e-05 | 419 | 187 | 14 | int:KRT18 |
| Interaction | RAN interactions | KPNA4 RANGAP1 NUP107 NUMA1 NUP98 ARAF NUP205 ASAP2 STXBP2 BRCA1 RAPGEF3 ANLN ATXN3 VCP PCNT | 3.91e-05 | 475 | 187 | 15 | int:RAN |
| Interaction | SQSTM1 interactions | KPNA4 PDE4A IQGAP2 MIS18A KHNYN CNTRL CEP290 FHOD3 DAXX CCDC61 USP19 TAOK2 GSTP1 BRCA1 CCT5 CAMKV ANLN CEP250 TAX1BP1 ATXN3 IQSEC1 EIF5B CCAR2 PIBF1 GOLGA1 VCP PCNT | 3.93e-05 | 1257 | 187 | 27 | int:SQSTM1 |
| Interaction | MAU2 interactions | 4.05e-05 | 136 | 187 | 8 | int:MAU2 | |
| Interaction | NUP54 interactions | 4.05e-05 | 136 | 187 | 8 | int:NUP54 | |
| Interaction | NUP107 interactions | KPNA4 RANGAP1 NUP107 NUMA1 NUP98 NUP205 BRCA1 PRKDC TP53BP1 VCP | 4.28e-05 | 221 | 187 | 10 | int:NUP107 |
| Interaction | ABTB2 interactions | 4.37e-05 | 101 | 187 | 7 | int:ABTB2 | |
| Interaction | CDC5L interactions | RANGAP1 MYH9 CAND1 NUP107 USB1 SPTAN1 DDX42 HNRNPM RNF17 SSUH2 MDN1 BRCA1 CCT5 HNRNPUL2 ANLN PDE4DIP YLPM1 PRKDC PLEC CPSF3 PCNT | 4.75e-05 | 855 | 187 | 21 | int:CDC5L |
| Interaction | JUP interactions | MYH9 DCAF6 SPTAN1 CEP290 CALML5 CFI ARAF SSUH2 BRCA1 GLDC ANLN PDE4DIP PRKDC PLEC VCP | 4.95e-05 | 485 | 187 | 15 | int:JUP |
| Interaction | FOXK2 interactions | SIN3B HNF1B NUP107 TRIM35 EIF5B CTBP1 EIF2AK3 THRAP3 CUX1 TP53BP1 | 4.98e-05 | 225 | 187 | 10 | int:FOXK2 |
| Interaction | STK3 interactions | 5.02e-05 | 181 | 187 | 9 | int:STK3 | |
| Interaction | SBDS interactions | 5.02e-05 | 181 | 187 | 9 | int:SBDS | |
| Cytoband | 17p13.1 | 1.41e-04 | 118 | 191 | 5 | 17p13.1 | |
| GeneFamily | Myosin heavy chains | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MYH15 | 2.06e-24 | 15 | 121 | 12 | 1098 |
| GeneFamily | Dyneins, axonemal | 1.86e-04 | 17 | 121 | 3 | 536 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 5.34e-04 | 24 | 121 | 3 | 654 | |
| GeneFamily | Nucleoporins | 1.26e-03 | 32 | 121 | 3 | 1051 | |
| GeneFamily | Adenylate kinases | 1.55e-03 | 9 | 121 | 2 | 356 | |
| GeneFamily | INO80 complex |SRCAP complex | 1.55e-03 | 9 | 121 | 2 | 1329 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | TCEA3 RANGAP1 NUP107 NSD2 MIS18A CNTRL HJURP NTMT1 RDM1 NCAPG2 MAP3K1 FBXL5 ZWINT NUP205 CENPP BICDL1 BRCA1 KIF15 HNRNPUL2 ANLN SYNE2 ATXN3 INTS4 POLQ CUX1 PCNT | 5.57e-09 | 939 | 191 | 26 | M45768 |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 3.70e-07 | 164 | 191 | 10 | M19957 | |
| Coexpression | FISCHER_DREAM_TARGETS | EME1 RANGAP1 CAND1 NUP107 UACA NSD2 MIS18A HJURP NUP98 RDM1 NCAPG2 ZWINT NUP205 CENPP BRCA1 KIF15 CCT5 ANLN PRKDC POLQ EIF2AK3 THRAP3 PCNT | 6.92e-07 | 969 | 191 | 23 | M149 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 2.16e-06 | 199 | 191 | 10 | M5893 | |
| Coexpression | HALLMARK_MYOGENESIS | 2.26e-06 | 200 | 191 | 10 | M5909 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | EME1 RANGAP1 NUP107 NSD2 MIS18A HJURP NCAPG2 ZWINT CENPP BRCA1 KIF15 APEX2 ANLN SYNE2 CTBP1 POLQ CPSF3 PCNT | 3.62e-06 | 694 | 191 | 18 | M45767 |
| Coexpression | FOURNIER_ACINAR_DEVELOPMENT_LATE_2 | MYH9 NUP107 NSD2 HJURP NCAPG2 ZWINT NUP205 RBM25 EIF5B PRKDC POLQ | 7.42e-06 | 281 | 191 | 11 | M4077 |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.21e-05 | 20 | 191 | 4 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.48e-05 | 21 | 191 | 4 | MM1102 | |
| Coexpression | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 1.71e-05 | 200 | 191 | 9 | M78 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | URI1 CAND1 ZNF148 DDX42 NUP98 NVL KLHL20 FAT1 ASAP2 ATP2C1 MDN1 PSME4 BRCA1 SYNE2 PIBF1 CUX1 TP53BP1 PCNT ANKS1A | 1.75e-05 | 856 | 191 | 19 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYH10 ZNF148 IQGAP2 CEP290 BRCA1 KIF15 ANLN TAX1BP1 ARHGAP44 SYNE2 ATXN3 EIF5B PIBF1 POLQ PDCD10 TCEAL9 | 2.71e-05 | 656 | 191 | 16 | M18979 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | MYH1 MYH3 MYH6 ZNF148 HJURP NUMA1 ARHGEF25 USP19 GSTP1 MFAP3 KRT75 PDE4DIP PLEC THRAP3 CUX1 | 4.44e-05 | 610 | 191 | 15 | M3854 |
| Coexpression | KANG_DOXORUBICIN_RESISTANCE_UP | 4.62e-05 | 54 | 191 | 5 | M1037 | |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN | 7.21e-05 | 187 | 191 | 8 | M34027 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | EME1 RANGAP1 UACA HJURP NCAPG2 NUP205 CENPP SH3PXD2B PSME4 BRCA1 KIF15 GLDC ANLN DKK3 | 7.66e-05 | 567 | 191 | 14 | M45692 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | MYH1 MYH3 MYH6 ZNF148 HJURP NUMA1 ARHGEF25 USP19 GSTP1 MFAP3 KRT75 PDE4DIP PLEC THRAP3 CUX1 | 9.03e-05 | 650 | 191 | 15 | MM1042 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGM | RERG IQGAP2 HJURP CFAP210 DNAH7 NCAPG2 FAT1 BRCA1 KIF15 HYDIN | 9.11e-05 | 307 | 191 | 10 | M39058 |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 9.31e-05 | 194 | 191 | 8 | M7467 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 9.67e-05 | 250 | 191 | 9 | M11318 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN | 1.07e-04 | 198 | 191 | 8 | M3401 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_TH2_DN | 1.07e-04 | 198 | 191 | 8 | M5535 | |
| Coexpression | GSE12366_GC_VS_NAIVE_BCELL_UP | 1.07e-04 | 198 | 191 | 8 | M3168 | |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_DN | 1.11e-04 | 199 | 191 | 8 | M3585 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | RANGAP1 NUP107 USB1 NSD2 HJURP RDM1 NCAPG2 ZWINT CENPP BRCA1 KIF15 ANLN INTS4 POLQ | 1.12e-04 | 588 | 191 | 14 | M38992 |
| Coexpression | HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 1.40e-04 | 68 | 191 | 5 | M41108 | |
| Coexpression | SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP | 1.41e-04 | 154 | 191 | 7 | M3766 | |
| Coexpression | GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN | 1.41e-04 | 154 | 191 | 7 | M6824 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 1.47e-04 | 155 | 191 | 7 | M39041 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | MYH1 MYH3 MYH6 ZNF148 HJURP NUMA1 ARHGEF25 USP19 GSTP1 MFAP3 KRT75 PLEC THRAP3 CUX1 | 1.79e-04 | 615 | 191 | 14 | M8673 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | RANGAP1 NSD2 HJURP NCAPG2 NUP205 FAT1 BRCA1 KIF15 ANLN POLQ TCEAL9 | 1.89e-04 | 402 | 191 | 11 | MM454 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 2.00e-04 | 163 | 191 | 7 | M8235 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | NSD2 MIS18A HJURP NCAPG2 F13A1 ZWINT BRCA1 KIF15 ANLN SYNE2 TCEAL9 PCNT | 2.15e-04 | 478 | 191 | 12 | M45785 |
| Coexpression | GSE21033_3H_VS_12H_POLYIC_STIM_DC_UP | 2.24e-04 | 166 | 191 | 7 | M7730 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C6_DEUTEROSOMAL_CELL | 2.28e-04 | 221 | 191 | 8 | M45789 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | URI1 ZNF148 DDX42 ZWINT FAT1 ATP2C1 UGDH CTBP1 PRKDC SLC9A6 CUX1 TP53BP1 | 2.28e-04 | 481 | 191 | 12 | M3898 |
| Coexpression | WIERENGA_PML_INTERACTOME | 2.46e-04 | 42 | 191 | 4 | M2219 | |
| Coexpression | DESCARTES_FETAL_EYE_SKELETAL_MUSCLE_CELLS | 2.59e-04 | 170 | 191 | 7 | M40176 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | EME1 SPTAN1 CEP290 NVL FHOD3 FBXO30 RBM25 ATP2C1 BRCA1 KIF15 GLDC ANLN EIF5B PRKDC PAN3 PIBF1 POLQ THRAP3 PCNT | 2.62e-07 | 532 | 187 | 19 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_200 | 1.33e-05 | 161 | 187 | 9 | gudmap_developingLowerUrinaryTract_P1_bladder_200_J | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | EME1 UACA CEP290 NVL FBXO30 ZWINT MFAP3 RBM25 KIF15 RAPGEF3 ANLN EIF5B PRKDC PAN3 PIBF1 | 1.86e-05 | 469 | 187 | 15 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.33e-05 | 192 | 187 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | EME1 RANGAP1 NSD2 HJURP RDM1 NCAPG2 ZWINT CENPP BRCA1 KIF15 ANLN POLQ | 2.97e-11 | 185 | 191 | 12 | 30e041d6f6e310d64809e9d6d93cd30052972f3b |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | EME1 NSD2 CNTRL HJURP RDM1 NCAPG2 ZWINT BRCA1 KIF15 ANLN SYNE2 POLQ | 6.96e-11 | 199 | 191 | 12 | be2276c9a1994579ba1d2998b49bf549c1324d44 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | EME1 NSD2 HJURP RDM1 NCAPG2 ZWINT CENPP BRCA1 KIF15 ANLN POLQ | 5.73e-10 | 187 | 191 | 11 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | RANGAP1 NSD2 CNTRL HJURP NCAPG2 ZWINT BRCA1 KIF15 ANLN SYNE2 POLQ | 1.11e-09 | 199 | 191 | 11 | 98575fcce726589e93fbb4df1aab03e57cb56076 |
| ToppCell | Mild-T/NK_proliferative|Mild / Disease group and Cell class | EME1 NSD2 MIS18A HJURP NCAPG2 ZWINT CENPP BRCA1 KIF15 ANLN POLQ | 1.11e-09 | 199 | 191 | 11 | 64a5c91243ee999ea21ffddd450d3e5fdbf6470b |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | RANGAP1 NSD2 CNTRL HJURP RDM1 NCAPG2 ZWINT BRCA1 KIF15 ANLN POLQ | 1.17e-09 | 200 | 191 | 11 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-09 | 169 | 191 | 10 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.51e-09 | 178 | 191 | 10 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.13e-09 | 180 | 191 | 10 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-09 | 180 | 191 | 10 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-09 | 187 | 191 | 10 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-08 | 194 | 191 | 10 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.26e-08 | 194 | 191 | 10 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-08 | 194 | 191 | 10 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.26e-08 | 194 | 191 | 10 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-08 | 197 | 191 | 10 | 7eb4c1cffd0366204af7e63adc8f751685601a94 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 1.52e-08 | 198 | 191 | 10 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 1.52e-08 | 198 | 191 | 10 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-08 | 198 | 191 | 10 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-08 | 198 | 191 | 10 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-08 | 198 | 191 | 10 | 8afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-08 | 198 | 191 | 10 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.60e-08 | 199 | 191 | 10 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | RANGAP1 UACA MIS18A CNTRL HJURP RDM1 NCAPG2 ZWINT KIF15 ANLN | 1.60e-08 | 199 | 191 | 10 | ca17e8c0f5bc2c41ce28351a7418d934404e563b |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.60e-08 | 199 | 191 | 10 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | distal-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.68e-08 | 200 | 191 | 10 | 0cd3b01fb7f579e5abf000adb8ec8adc7cd779c4 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 1.68e-08 | 200 | 191 | 10 | 381bafdde6492f020ae93ab8fffa6215c631c570 | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.68e-08 | 200 | 191 | 10 | 61473e8613f39a92002d5b631e6bd563735566e4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-08 | 166 | 191 | 9 | 2642544070564debe2deb2938d2c33997bf5ef02 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.90e-08 | 168 | 191 | 9 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | Club-club-15|World / Class top | 6.96e-08 | 175 | 191 | 9 | ca9d012f520f697c7450ec6958a015e20538a6a8 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 7.31e-08 | 176 | 191 | 9 | a40dfd8c4ba16757ff929b2f03a0628acf334de4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-08 | 179 | 191 | 9 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-08 | 179 | 191 | 9 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.86e-08 | 180 | 191 | 9 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-07 | 187 | 191 | 9 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-07 | 189 | 191 | 9 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-07 | 190 | 191 | 9 | 185ae04c68f825cd346aa65072cc5da6a39dff4a | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.40e-07 | 190 | 191 | 9 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-07 | 190 | 191 | 9 | e38dc41f2e79e3bd51326581c6ebe51927edb549 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.60e-07 | 193 | 191 | 9 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.75e-07 | 195 | 191 | 9 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.75e-07 | 195 | 191 | 9 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.75e-07 | 195 | 191 | 9 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 1.75e-07 | 195 | 191 | 9 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-07 | 195 | 191 | 9 | 47a01b8a92eebeb34ac7f70bf1ab4613a326e24f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.83e-07 | 196 | 191 | 9 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | Healthy-T/NK_proliferative|Healthy / disease group, cell group and cell class | 1.83e-07 | 196 | 191 | 9 | 91e44aabb2e85dcc77ddae6f7e000118d45d1de6 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 1.83e-07 | 196 | 191 | 9 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.91e-07 | 197 | 191 | 9 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.91e-07 | 197 | 191 | 9 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | Healthy-T/NK_proliferative|World / disease group, cell group and cell class | 1.91e-07 | 197 | 191 | 9 | e90be1e7e02f736b6aab14010a912b592d6f1e80 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-07 | 197 | 191 | 9 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-07 | 197 | 191 | 9 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.91e-07 | 197 | 191 | 9 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.91e-07 | 197 | 191 | 9 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 1.91e-07 | 197 | 191 | 9 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.91e-07 | 197 | 191 | 9 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.91e-07 | 197 | 191 | 9 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-07 | 197 | 191 | 9 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | distal-Hematologic-Proliferating_NK/T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.91e-07 | 197 | 191 | 9 | 04b10879e48c101d1de449db0bc6b6484090b965 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.91e-07 | 197 | 191 | 9 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.91e-07 | 197 | 191 | 9 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 1.91e-07 | 197 | 191 | 9 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 1.99e-07 | 198 | 191 | 9 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | distal-2-Hematologic-Proliferating_NK/T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.99e-07 | 198 | 191 | 9 | a5fd710df5669c95fc5b5ef6e5cfafe6687c7b72 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 1.99e-07 | 198 | 191 | 9 | 47d572b9db2843aeb2079f33a852babf67270be4 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 1.99e-07 | 198 | 191 | 9 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.08e-07 | 199 | 191 | 9 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 2.08e-07 | 199 | 191 | 9 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-T_NK_proliferative|Leuk-UTI / Disease, Lineage and Cell Type | 2.08e-07 | 199 | 191 | 9 | 87113d398585076ece86b9098781e817f8ca241b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.08e-07 | 199 | 191 | 9 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 2.08e-07 | 199 | 191 | 9 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 2.08e-07 | 199 | 191 | 9 | 2e9ee10a069afca5dbd9f0863cf90a66db1a6ffb | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.08e-07 | 199 | 191 | 9 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.08e-07 | 199 | 191 | 9 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.08e-07 | 199 | 191 | 9 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | severe_influenza-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 2.08e-07 | 199 | 191 | 9 | 1541f655f7d12c650added3683d07e5417a68dfb | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 2.08e-07 | 199 | 191 | 9 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.08e-07 | 199 | 191 | 9 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 2.08e-07 | 199 | 191 | 9 | 6321140a1ebc1ff793fb6221a31e884368e42fa5 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.08e-07 | 199 | 191 | 9 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.08e-07 | 199 | 191 | 9 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|COVID-19 / Condition, Lineage and Cell class | 2.08e-07 | 199 | 191 | 9 | e1dfc856a85a91e8f7ab8d600a8a891d16b2aefb | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.08e-07 | 199 | 191 | 9 | 123fbf2122aa221d8cbf3aef9361ba0982c07695 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.08e-07 | 199 | 191 | 9 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 2.08e-07 | 199 | 191 | 9 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | Healthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 2.08e-07 | 199 | 191 | 9 | 1311dfd74b991f48b047a439f04f9bf7dfaa0e7a | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.08e-07 | 199 | 191 | 9 | fba48342066aab41a8bcb20db40a6df0158e1cbe | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-07 | 199 | 191 | 9 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 2.08e-07 | 199 | 191 | 9 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | distal-Hematologic-Proliferating_NK/T|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.08e-07 | 199 | 191 | 9 | 4f02e03c118744fba0dfc5e3ed6dea4041f3d089 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.08e-07 | 199 | 191 | 9 | 6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / disease group, cell group and cell class | 2.08e-07 | 199 | 191 | 9 | af78837f3a7641a5bd98765eef9cb4f86034048c | |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.08e-07 | 199 | 191 | 9 | df2fcaf01b1b48632f84e7355ef21d20853f0664 | |
| ToppCell | (1)_T_cell-(18)_cycling_gd_T|(1)_T_cell / shred on Cell_type and subtype | 2.08e-07 | 199 | 191 | 9 | 9369d0e4efe809e3e8757294ebebba5a47b30528 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 2.08e-07 | 199 | 191 | 9 | cefcfe639a3396bccf2354ca605a1e18b964fbf2 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.17e-07 | 200 | 191 | 9 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Mild / Disease, condition lineage and cell class | 2.17e-07 | 200 | 191 | 9 | 6126a3bbafe2110fba0c1c4493035df4e8193d22 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | 2.17e-07 | 200 | 191 | 9 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 | |
| Computational | Intermediate filaments and MT. | 8.59e-07 | 68 | 121 | 8 | MODULE_438 | |
| Drug | formycin triphosphate | 3.64e-13 | 51 | 190 | 11 | CID000122274 | |
| Drug | N-ethylmaleimide | KIF13B MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B SPTAN1 CHRM2 GSTP1 STX1A ATP2C1 STXBP2 KIF15 ACTR6 CARD6 POLQ SLC12A7 VCP ALPI | 1.25e-12 | 511 | 190 | 25 | CID000004362 |
| Drug | fast white | 1.51e-12 | 42 | 190 | 10 | CID000024008 | |
| Drug | purealin | 1.65e-12 | 58 | 190 | 11 | CID006419303 | |
| Drug | blebbistatin | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B ANLN ACTR6 | 1.64e-11 | 116 | 190 | 13 | CID003476986 |
| Drug | B0683 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B ACTR6 MYBPC2 | 1.83e-11 | 117 | 190 | 13 | CID006398969 |
| Drug | trifluoperazine | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MAP2 MYH7B SPTAN1 SST CHRM2 AK7 ATP2C1 ACTR6 PRKCB | 3.43e-11 | 324 | 190 | 19 | CID000005566 |
| Drug | SM-2 | 1.65e-10 | 87 | 190 | 11 | CID000486033 | |
| Drug | NSC339663 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 KRT14 MYH7B KRT75 ACTR6 SYNE2 PLEC | 3.64e-10 | 250 | 190 | 16 | CID000003892 |
| Drug | nocodazole | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 RANGAP1 MYH8 MYH9 MYH10 MYH11 MAP2 MYH7B NUMA1 MAP3K1 ZWINT TAOK2 STXBP2 ACTR6 GOLGA1 PCNT | 6.09e-10 | 477 | 190 | 21 | CID000004122 |
| Drug | S-(-)-Etomoxir | 7.59e-10 | 100 | 190 | 11 | CID000060765 | |
| Drug | AC1LADJ6 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B ACTR6 | 9.84e-10 | 130 | 190 | 12 | CID000486032 |
| Drug | carvedilol | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B MMP27 CHRM2 | 1.02e-09 | 161 | 190 | 13 | CID000002585 |
| Drug | D-triiodothyronine | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B SST GSTP1 ATP2C1 ACTR6 PRKCB CTBP1 THRAP3 ALPI | 1.74e-09 | 409 | 190 | 19 | CID000000861 |
| Drug | AC1NRBPQ | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH10 MYH11 MYH7B ACTR6 CCAR2 | 1.80e-09 | 137 | 190 | 12 | CID005288569 |
| Drug | candesartan cilexetil | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B ACTR6 | 3.46e-09 | 145 | 190 | 12 | CID000002540 |
| Drug | NSC107658 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B SPTAN1 ARHGEF25 KLHL20 ACTR6 PRKCB | 6.75e-09 | 306 | 190 | 16 | CID000002919 |
| Drug | clenbuterol | 3.15e-08 | 142 | 190 | 11 | CID000002783 | |
| Drug | verapamil | CACNA1F MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B SST KCNB2 CHRM2 GSTP1 ATP2C1 PRKCB ALPI | 3.22e-08 | 490 | 190 | 19 | CID000002520 |
| Drug | oxovanadium | 6.78e-08 | 120 | 190 | 10 | CID000024411 | |
| Drug | wartmannin | MYH1 MYH2 MYH3 MYH4 HNF1B MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B CHRM2 ARAF MAP3K1 STX1A RAPGEF3 ACTR6 PI4KB PRKCB PRKDC CUX1 TP53BP1 ALPI | 8.03e-08 | 811 | 190 | 24 | CID000005691 |
| Drug | 2bq7 | 8.57e-08 | 123 | 190 | 10 | CID006540267 | |
| Drug | 4-chloroaniline | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH10 MYH11 MYH7B GSTP1 ACTR6 | 1.40e-07 | 202 | 190 | 12 | CID000007812 |
| Drug | AC1L1IZ2 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B AK7 ACTR6 VCP | 2.91e-07 | 304 | 190 | 14 | CID000004795 |
| Drug | NSC611747 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH10 MYH11 MYH7B ARAF MAP3K1 ACTR6 PRKCB SLC12A7 | 2.93e-07 | 352 | 190 | 15 | CID000002534 |
| Drug | MgCl2 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B SPTAN1 PRPS1L1 ATP2C1 ACTR6 | 3.15e-07 | 354 | 190 | 15 | CID000024584 |
| Drug | carbachol | CACNA1F MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B SST CHRM2 ATP2C1 HNRNPUL2 RAPGEF3 ACTR6 PI4KB PRKCB IL9R | 3.34e-07 | 688 | 190 | 21 | CID000002551 |
| Drug | nifedipine | CACNA1F MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B CHRM2 ATP2C1 PRKCB EIF2AK3 | 4.46e-07 | 415 | 190 | 16 | CID000004485 |
| Drug | eye gene | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B CHRM2 MAP3K1 ACTR6 PRKCB | 5.32e-07 | 369 | 190 | 15 | CID000004782 |
| Drug | NSC226080 | MYH1 MYH2 MYH3 MYH4 HNF1B MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 URI1 MYH7B ARAF PSME4 ACTR6 PI4KB EIF5B PRKCB EIF2AK3 CUX1 ALPI | 6.81e-07 | 782 | 190 | 22 | CID000005040 |
| Drug | creatine | 7.10e-07 | 193 | 190 | 11 | CID000000586 | |
| Drug | isoproterenol | CACNA1F MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 PDE4A MYH11 URI1 UACA MYH7B SST CHRM2 RAPGEF3 ACTR6 PRKCB | 8.95e-07 | 669 | 190 | 20 | CID000003779 |
| Drug | LY294002 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B ARAF RAPGEF3 ACTR6 PI4KB PRKCB PRKDC EIF2AK3 CUX1 ALPI | 4.85e-06 | 748 | 190 | 20 | CID000003973 |
| Drug | radicicol; Up 200; 0.1uM; HL60; HG-U133A | KIF13B RANGAP1 URI1 EP400 NSD2 KHNYN TAOK2 STX1A ATP2C1 GOLGA1 | 5.38e-06 | 193 | 190 | 10 | 544_UP |
| Drug | K-Cl | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH9 MYH10 MYH11 MYH7B SST CHRM2 ATP2C1 ACTR6 POLQ SLC12A7 | 5.92e-06 | 567 | 190 | 17 | CID000004873 |
| Drug | Gabapentin [60142-96-3]; Down 200; 23.4uM; HL60; HT_HG-U133A | USB1 CEP290 SRCAP MAP3K1 TAOK2 STX1A PDE4DIP IQSEC1 MYH15 SLC12A7 | 7.06e-06 | 199 | 190 | 10 | 2731_DN |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 3.00e-05 | 188 | 190 | 9 | 4845_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 3.68e-05 | 193 | 190 | 9 | 1284_DN | |
| Drug | AC1N9ZZC | 3.71e-05 | 149 | 190 | 8 | CID004369374 | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; HL60; HG-U133A | 3.99e-05 | 195 | 190 | 9 | 2004_DN | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; HL60; HG-U133A | 3.99e-05 | 195 | 190 | 9 | 1979_DN | |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; PC3; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 6591_UP | |
| Drug | Pentylenetetrazole [54-95-5]; Up 200; 29uM; HL60; HG-U133A | HNF1B CAND1 SRCAP APOBR ATP2C1 CAMKV HNRNPUL2 YLPM1 FAM149B1 | 4.32e-05 | 197 | 190 | 9 | 1408_UP |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 5482_DN | |
| Drug | Altretamine [654-05-6]; Up 200; 19uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 6467_UP | |
| Drug | flufenamic acid; Up 200; 10uM; MCF7; HG-U133A | 4.49e-05 | 198 | 190 | 9 | 316_UP | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; HL60; HG-U133A | 4.67e-05 | 199 | 190 | 9 | 1588_DN | |
| Drug | aluminum fluoride | RANGAP1 MYH11 MYH7B ARHGEF25 CHRM2 CCT5 HNRNPUL2 ACTR6 PRKCB VCP | 8.96e-05 | 268 | 190 | 10 | CID000002124 |
| Drug | Methamphetamine | KPNA4 KRT7 MYH6 MYH7 RTP1 KRT14 EP400 MAP2 SPTAN1 HJURP ARHGEF25 TAOK2 CITED2 GSTP1 RBM25 ALDH1A2 BRCA1 KIF15 CCT5 APEX2 RAPGEF3 PDE4DIP PLEC EIF2AK3 CUX1 PCNT | 1.09e-04 | 1401 | 190 | 26 | ctd:D008694 |
| Drug | 4-epidoxorubicin | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH10 MYH11 MYH7B TAOK2 GSTP1 DHDH BRCA1 PRKCB POLQ CEP170B CUX1 | 1.13e-04 | 788 | 190 | 18 | CID000001690 |
| Drug | sodium dodecyl sulfate | 1.16e-04 | 91 | 190 | 6 | CID000008778 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.05e-19 | 10 | 182 | 9 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.05e-19 | 10 | 182 | 9 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.05e-19 | 10 | 182 | 9 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.05e-19 | 10 | 182 | 9 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.05e-19 | 10 | 182 | 9 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.05e-19 | 10 | 182 | 9 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.05e-19 | 10 | 182 | 9 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.05e-19 | 10 | 182 | 9 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 2.29e-18 | 12 | 182 | 9 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.29e-18 | 12 | 182 | 9 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 7.41e-18 | 13 | 182 | 9 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 5.13e-17 | 15 | 182 | 9 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 3.32e-13 | 48 | 182 | 10 | DOID:423 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.07e-11 | 71 | 182 | 10 | DOID:0050700 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.69e-09 | 80 | 182 | 9 | DOID:12930 (implicated_via_orthology) | |
| Disease | Dickkopf-related protein 3 measurement | 1.13e-04 | 3 | 182 | 2 | EFO_0008109 | |
| Disease | Malignant neoplasm of breast | MYH1 RTP1 MYH9 KRT14 NSD2 SPTAN1 NUP98 ARAF MAP3K1 GSTP1 BRCA1 CCT5 TAX1BP1 SYNE2 CNGA2 CPSF3 CUX1 TP53BP1 | 1.25e-04 | 1074 | 182 | 18 | C0006142 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.71e-04 | 45 | 182 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 2.25e-04 | 4 | 182 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 2.25e-04 | 4 | 182 | 2 | cv:C3495498 | |
| Disease | Caveolinopathy | 2.25e-04 | 4 | 182 | 2 | cv:C5679790 | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 2.25e-04 | 4 | 182 | 2 | 192600 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.31e-04 | 139 | 182 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | Adenocarcinoma of large intestine | 3.28e-04 | 96 | 182 | 5 | C1319315 | |
| Disease | Limb-girdle muscular dystrophy | 5.41e-04 | 26 | 182 | 3 | cv:C0686353 | |
| Disease | 4p partial monosomy syndrome | 5.58e-04 | 6 | 182 | 2 | cv:C1956097 | |
| Disease | WOLF-HIRSCHHORN SYNDROME | 5.58e-04 | 6 | 182 | 2 | 194190 | |
| Disease | kidney disease (is_implicated_in) | 5.58e-04 | 6 | 182 | 2 | DOID:557 (is_implicated_in) | |
| Disease | Central hypotonia | 5.58e-04 | 6 | 182 | 2 | C1842364 | |
| Disease | inclusion body myositis (is_implicated_in) | 5.58e-04 | 6 | 182 | 2 | DOID:3429 (is_implicated_in) | |
| Disease | Hyalinosis, Segmental Glomerular | 6.75e-04 | 28 | 182 | 3 | C0086432 | |
| Disease | orofacial cleft (is_implicated_in) | 7.79e-04 | 7 | 182 | 2 | DOID:0050567 (is_implicated_in) | |
| Disease | 1-palmitoyl-GPE (16:0) measurement | 7.79e-04 | 7 | 182 | 2 | EFO_0800245 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 7.79e-04 | 7 | 182 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 7.79e-04 | 7 | 182 | 2 | C0700053 | |
| Disease | Obstructive asymmetric septal hypertrophy | 7.79e-04 | 7 | 182 | 2 | C0597124 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 7.79e-04 | 7 | 182 | 2 | C0751337 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 8.29e-04 | 30 | 182 | 3 | C1868672 | |
| Disease | Pitt-Rogers-Danks Syndrome | 1.03e-03 | 8 | 182 | 2 | C0796117 | |
| Disease | Aqueductal Stenosis | 1.03e-03 | 8 | 182 | 2 | C2936786 | |
| Disease | PR interval | KIF13B MYH7 MYH11 CHRM2 PRPS1L1 FAT1 SYNE2 PLEC SLC12A7 THRAP3 | 1.06e-03 | 495 | 182 | 10 | EFO_0004462 |
| Disease | radius bone mineral density | 1.20e-03 | 34 | 182 | 3 | EFO_0007933 | |
| Disease | Distal arthrogryposis | 1.32e-03 | 9 | 182 | 2 | cv:C0265213 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 1.32e-03 | 9 | 182 | 2 | C0949658 | |
| Disease | longitudinal alcohol consumption measurement | 1.32e-03 | 9 | 182 | 2 | EFO_0007645 | |
| Disease | Wolf-Hirschhorn Syndrome | 1.32e-03 | 9 | 182 | 2 | C1956097 | |
| Disease | Ostium secundum atrial septal defect | 1.32e-03 | 9 | 182 | 2 | C0344724 | |
| Disease | Disproportionate short stature | 1.33e-03 | 77 | 182 | 4 | C0878659 | |
| Disease | Primary ciliary dyskinesia | 1.42e-03 | 36 | 182 | 3 | cv:C0008780 | |
| Disease | Focal glomerulosclerosis | 1.42e-03 | 36 | 182 | 3 | C0017668 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.54e-03 | 37 | 182 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | HNF1B DCAF6 STAB2 MAP3K1 GSTP1 ALDH1A2 DHDH BRCA1 INTS4 PRKDC VCP | 1.62e-03 | 616 | 182 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | HNF1B DCAF6 STAB2 MAP3K1 GSTP1 ALDH1A2 DHDH BRCA1 INTS4 PRKDC VCP | 1.62e-03 | 616 | 182 | 11 | C0376358 |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 1.65e-03 | 10 | 182 | 2 | cv:C5675009 | |
| Disease | Parkinson Disease | 1.92e-03 | 85 | 182 | 4 | C0030567 | |
| Disease | resting heart rate | 2.36e-03 | 149 | 182 | 5 | EFO_0004351 | |
| Disease | triglycerides in large LDL measurement | 2.38e-03 | 43 | 182 | 3 | EFO_0022319 | |
| Disease | Primary Ciliary Dyskinesia | 3.07e-03 | 47 | 182 | 3 | C4551720 | |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 3.28e-03 | 14 | 182 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | Left ventricular noncompaction | 3.28e-03 | 14 | 182 | 2 | C1960469 | |
| Disease | Adenoid Cystic Carcinoma | 3.47e-03 | 100 | 182 | 4 | C0010606 | |
| Disease | unipolar depression, cognitive function measurement | 3.77e-03 | 15 | 182 | 2 | EFO_0003761, EFO_0008354 | |
| Disease | mean platelet volume | MYH9 MYH11 IQGAP2 NUMA1 SRCAP APOBR PRPS1L1 SYNE2 INTS4 PLEC PDCD10 SLC12A7 CUX1 ANKS1A | 4.48e-03 | 1020 | 182 | 14 | EFO_0004584 |
| Disease | Muscle hypotonia | 4.84e-03 | 17 | 182 | 2 | C0026827 | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 4.84e-03 | 17 | 182 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 4.84e-03 | 17 | 182 | 2 | OBA_2045173 | |
| Disease | alpha-L-iduronidase measurement | 4.84e-03 | 17 | 182 | 2 | EFO_0020139 | |
| Disease | triglycerides in large VLDL measurement | 5.03e-03 | 56 | 182 | 3 | EFO_0022178 | |
| Disease | triglycerides in LDL measurement | 5.03e-03 | 56 | 182 | 3 | EFO_0022320 | |
| Disease | triglycerides in very large VLDL measurement | 5.03e-03 | 56 | 182 | 3 | EFO_0022325 | |
| Disease | Hypertrophic Cardiomyopathy | 5.29e-03 | 57 | 182 | 3 | C0007194 | |
| Disease | Mammary Carcinoma, Human | 5.50e-03 | 525 | 182 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 5.50e-03 | 525 | 182 | 9 | C1257931 | |
| Disease | immature platelet fraction | 5.52e-03 | 114 | 182 | 4 | EFO_0009187 | |
| Disease | Mammary Neoplasms | 5.63e-03 | 527 | 182 | 9 | C1458155 | |
| Disease | hydrocephalus (implicated_via_orthology) | 6.04e-03 | 19 | 182 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in large HDL percentage | 6.10e-03 | 60 | 182 | 3 | EFO_0022330 | |
| Disease | total lipids in VLDL measurement | 6.10e-03 | 60 | 182 | 3 | EFO_0022314 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MQELRVRLAEAEETA | 861 | Q8N163 | |
| ISENDDFEDMVVTRE | 366 | Q9GZN1 | |
| SVSLMEVLAREDIDE | 26 | Q86W67 | |
| SIEQEKERNSEDAVM | 2176 | Q96L91 | |
| GQVLELEVEDRMTAD | 26 | Q9Y6R9 | |
| QEETEILTADMDAER | 301 | P05156 | |
| VEQERDQLEIVAMDA | 656 | Q7Z7A1 | |
| RAGMDTADLEQAVEV | 311 | Q86VW2 | |
| EQASIEMREEAAREI | 321 | Q13363 | |
| DDESLREMVELAAQR | 661 | Q9UKF6 | |
| SDVEEQEAAIMDIVI | 296 | Q9NZJ5 | |
| DLVERDRAVLATMES | 111 | O94788 | |
| SEGEEMDTAEIARQV | 546 | P39880 | |
| TVLVQEMREAFEQEA | 156 | Q9BZP6 | |
| AVASNMRDDEITQDE | 291 | P08172 | |
| NVMEEQDLRDIGISD | 731 | Q92625 | |
| LADEVITRNELMLEE | 801 | Q58WW2 | |
| MDEFTQEELRALDSE | 116 | Q9UBZ4 | |
| DEVVTIDDVQVARME | 1566 | Q9P1Z9 | |
| AQDTEVEEARKMIDQ | 576 | Q9Y4F5 | |
| LEGVNRSIEEVEADM | 341 | O60826 | |
| SMEAEELEQEREQLR | 351 | Q6ZP65 | |
| QEELDAMIREADVDQ | 116 | Q9NZT1 | |
| MDAELAEVRALQAEI | 1 | Q6IPU0 | |
| MATANSIIVLDDDDE | 1 | Q9UER7 | |
| EAADMILVDDDFQTI | 671 | P98194 | |
| RAMEGEDVEDDQLLQ | 6 | Q8NCD3 | |
| DEMSLIQDDVDLRDT | 386 | Q9NXG6 | |
| KDEATVRMAVQDAVD | 481 | P46060 | |
| EQDIVEMVSLAAEES | 436 | Q9H4I0 | |
| SILDDVAMVLDEEAE | 806 | P49756 | |
| LVDMFNDEIEEVRLQ | 416 | Q96HW7 | |
| TEDVTISAVMLREDD | 131 | P57740 | |
| ADIGALEDIREELTM | 581 | O15381 | |
| EDLMVDVERSNAAAA | 1426 | P12883 | |
| ISFIEQSTEERDDMI | 281 | Q92621 | |
| LDEDRVVDELDNQMR | 56 | Q9Y3D8 | |
| ELSDLEERENEDSMV | 136 | Q8NG50 | |
| REEARAQEAAEFEEM | 171 | Q86V59 | |
| MRQALTCDTEEEEEE | 1631 | O60840 | |
| EDAVLEQSVITVMAD | 3346 | Q14517 | |
| DMARAAVDEAIQEGL | 121 | Q9H306 | |
| AEAAEDDEIRMINEF | 3036 | Q96JQ0 | |
| EVEQLGRVVELDSDM | 936 | P52948 | |
| DEEDVDMALDQRFSR | 1001 | P52948 | |
| VEDFSEQMEIAIRAI | 4501 | Q9NU22 | |
| DNRQRDTVVEDMLED | 846 | Q6DN14 | |
| MEDRAQAIIDTTDDA | 611 | Q8TD91 | |
| EIVSVAMAQALEEVR | 476 | Q92805 | |
| EMNEQAFEAISEELR | 706 | Q9NS87 | |
| ERSMATVDEEEQAVL | 291 | Q8IVD9 | |
| RASVSVMEEEFLLEA | 496 | Q6ZRS4 | |
| EEMSALIEERDAALS | 261 | Q8TD10 | |
| RLEAELRSMQDVVED | 161 | P08729 | |
| DELTLARADLEMQIE | 226 | P02533 | |
| MAEAALEAVRSELRE | 1 | P0C870 | |
| AVEMALEDVNSRRDI | 191 | Q9UBS5 | |
| VIREIEMSVDDDDIN | 546 | Q9NQW6 | |
| TVAAIEEALDVDRMV | 36 | O43150 | |
| NRDVLDCVVDEMDFS | 586 | Q6DN90 | |
| RALALSRQEIDMEDE | 231 | P54252 | |
| SRQEIDMEDEEADLR | 236 | P54252 | |
| EAAAEVAATEIKMEE | 6 | P52272 | |
| LDANEDDNEIVREMT | 526 | Q8IVV2 | |
| EDVSVQLEALDIMAD | 146 | Q86VP6 | |
| LEAFMAEVEDQAARD | 116 | Q86XP3 | |
| SELRMEVDDLAANVE | 1271 | A7E2Y1 | |
| IDDQEELMATDSAID | 326 | P13535 | |
| NEVEDLMLDVERSNA | 1426 | P13535 | |
| FTESLLRMAADDVEE | 76 | Q9BUL8 | |
| IDDQEELMATDSAID | 326 | Q9UKX2 | |
| VEDLMLDVERTNAAC | 1431 | Q9UKX2 | |
| LEVMAQEASLEAELE | 761 | P27815 | |
| IVQAEEAASMSVEER | 326 | O96028 | |
| EVAALARQAEDEFML | 256 | Q8N819 | |
| QRLQEALDAEMLEDE | 31 | Q1KMD3 | |
| EGQEEERLALETALM | 486 | P00488 | |
| DVVIQDDDVECTMVE | 376 | P05771 | |
| IDDQEELMATDSAIE | 326 | P12882 | |
| LQRELEDATETADAM | 1896 | P35579 | |
| NVALREAEVEDMASR | 1841 | O95613 | |
| EAEVEDMASRIQEFE | 1846 | O95613 | |
| VLEDVDFDQMVSLEA | 21 | P55082 | |
| ALTEAVMFDDAIERA | 346 | P09923 | |
| QLDAAQMRNDVIEED | 756 | Q58A45 | |
| RETSIEMEESELDAQ | 841 | P38398 | |
| VADTRFDMVQLIDVA | 396 | P10398 | |
| ELSEAQVLDAAMEES | 166 | Q8NBI3 | |
| EERVSMERGEDQALL | 651 | Q8N9C0 | |
| TEIIEDNDMEDLVAA | 3636 | Q4G0P3 | |
| QTEVVIRDIDERAME | 106 | Q9Y2M5 | |
| DAFARSMELIDVAVE | 456 | Q92953 | |
| MAALARELGIQVDED | 646 | Q9BX69 | |
| LMEVEQDQRITAEEA | 266 | Q8NCB2 | |
| LEDNTDLIEMREEVS | 956 | Q9UFH2 | |
| IRLAEMEQTVAEQDD | 1621 | O15078 | |
| TEREAAALIVEEARM | 871 | O75417 | |
| TEMEAIQAQREEERT | 896 | Q9BV73 | |
| AVASRFLEEIEMSEE | 2511 | Q8WXX0 | |
| NVTDDAADEIMDRIV | 1356 | Q2V2M9 | |
| EDEVISQEDMNKVRD | 31 | P57730 | |
| EAALVDMVNDGVEDL | 86 | P09211 | |
| VNAAEVREMVAEARS | 101 | Q9UQ10 | |
| EAFVMAQSRVEELAE | 126 | O15037 | |
| SMVSRVDAEEALVDL | 401 | Q96AY2 | |
| MLDAEDLADIEDTVE | 481 | Q9UKA1 | |
| QVSREDMDFLLDEID | 501 | Q6ZQY3 | |
| SRDVDEVAQLDMALA | 111 | Q8TB52 | |
| AEVEVVEMVENDISA | 906 | Q9Y666 | |
| GSFMEEVRQELEDLE | 311 | Q9UBP4 | |
| HNSMEDARELDEEVV | 1441 | Q96RY7 | |
| RIILEDENDAMADAD | 61 | Q9BUN1 | |
| LQAETELFAEAEEMR | 896 | P35580 | |
| TREAVVARLADDMLE | 4351 | Q8TE73 | |
| LLQALDEMRADAEAV | 601 | Q8WZA9 | |
| ETEVLRRELAEAMAA | 781 | Q14980 | |
| MERDEEDSIIVSEGI | 211 | Q96BN6 | |
| EEAAEQRAEVDRMLS | 101 | P35680 | |
| LMAIADEVEIAEAIQ | 856 | Q13233 | |
| EVDMVDITEDFLVQA | 86 | Q9BV86 | |
| EEREALARMAANVEN | 1316 | Q9NQT8 | |
| DESSMLEENIEGLVD | 141 | P59025 | |
| AENILSIDEMDLEVR | 111 | A5PLK6 | |
| EFLRVEEQAILDAMA | 196 | Q9UPQ4 | |
| EEQAILDAMAEETRQ | 201 | Q9UPQ4 | |
| VEEEVVNADISEMLR | 536 | Q2YD98 | |
| ELSDAVNVRDRTMAD | 376 | Q86VP1 | |
| MSDAAGDIVDIREEI | 151 | O94763 | |
| RAMDEEIVSEKQAEE | 51 | Q92581 | |
| VLDQDDVDTSMEESL | 756 | Q8WXH0 | |
| EQQRVGLAVDMDEIE | 781 | P0DPF2 | |
| EQQRVGLAVDMDEIE | 2001 | P0DPF2 | |
| EQQRVGLAVDMDEIE | 3221 | P0DPF2 | |
| SIVDDERLSAEEMDE | 16 | Q13576 | |
| DDAEELLATEQAMDI | 336 | Q9Y2K3 | |
| AFDVRIERDAQEMAD | 1036 | O60841 | |
| ELTMDDDTAVLVIDN | 661 | P0CG39 | |
| MTIELLDTEEAQTED | 966 | O75182 | |
| NAVLTVADMERRDVD | 191 | P48643 | |
| EAVLDQRMLGEEEEA | 781 | Q9UL54 | |
| IDDQEELMATDSAVD | 326 | Q9Y623 | |
| VEDLMVDVERANSLA | 1426 | P11055 | |
| EARLRVQMATLEDDV | 221 | Q01113 | |
| SDQADAILREDMEQI | 736 | Q9BZV3 | |
| EDEEMSRAEQEIAAL | 2291 | Q6ZRS2 | |
| ERLEDEEEMNAELTA | 926 | P13533 | |
| EIEDLMVDVERSNAA | 1426 | P13533 | |
| QIREEEDEMGAAVAS | 96 | Q9UBF8 | |
| VNDRVAILVDDMADT | 211 | P21108 | |
| ADALREEMEEAANRV | 176 | Q17R89 | |
| EEMEEAANRVEICRD | 181 | Q17R89 | |
| LTDEEAEAMIQAADT | 96 | A0A1B0GWK0 | |
| QATIDDEVVSMEILD | 46 | Q96A58 | |
| DEVVSMEILDTAGQE | 51 | Q96A58 | |
| MDRDLNEDDSVVDLS | 1 | Q9Y2M2 | |
| DRARMEELVQAEEAQ | 481 | Q0VD83 | |
| LDNEDMIIARDIAEA | 341 | Q0VFZ6 | |
| NVIDTDFIDEEVLMS | 216 | Q99967 | |
| TDSDEEVAMLLDTVQ | 941 | Q86XI2 | |
| EGLLDENEVATSMEV | 581 | Q16280 | |
| EADLMQLQEDLAAAE | 1686 | P35749 | |
| VMLDTNTAEEIDEAL | 141 | Q9BXT8 | |
| ADVEEVATAIGMDQR | 246 | O60701 | |
| MSSEDREAQEDELLA | 1 | Q9UBS8 | |
| EMEEELAEAVALLSQ | 196 | O95398 | |
| DRIIEVDMECQTDAF | 266 | Q86UC2 | |
| LEVMEEEELANLRAS | 331 | Q86UC2 | |
| MEAAETEAEAAALEV | 1 | O95229 | |
| EEMAVAADAATLVDE | 261 | O94966 | |
| EAQVNVRMDSFDEDL | 566 | Q9Y2W1 | |
| SEDASVADMERAQLE | 56 | Q9NYP9 | |
| VADMERAQLEEEAAA | 61 | Q9NYP9 | |
| DLEDETIDAEVMNSL | 431 | P55072 | |
| LMEDGSIRIEEATEE | 376 | Q9UPX0 | |
| DQDEMNLERGAVVEV | 236 | A1X283 | |
| DDDDVAVTVDRDRFM | 16 | Q16623 | |
| DLESEGLMAEEVQAV | 1156 | Q13813 | |
| LELQEDDVVVMATDG | 371 | Q96MI6 | |
| DVMEDAVEDRLDRNL | 481 | Q15833 | |
| IMQTAEIENEDEAER | 541 | Q8WXW3 | |
| VAELATMEVESARLD | 231 | Q9NRS6 | |
| ILANDVAMEEIEITA | 626 | Q8WWQ8 | |
| SNEDMFREVDEIDEI | 66 | Q9UHQ7 | |
| TAEEMASDELRELRN | 271 | O75764 | |
| EALSSVLDQEEAMEI | 636 | Q12888 | |
| DQEGELRSEDVMDLT | 41 | A6NLC8 | |
| EAERQRQLEMSAEAE | 2506 | Q15149 | |
| VAEMSRAQARAEEDA | 2526 | Q15149 | |
| QFLDLVSEVDRVMEE | 181 | Q9BQ65 | |
| ISLLEDEQLEVREMA | 1691 | Q14997 | |
| SLLQDAAIEEVEMED | 2001 | P49750 | |
| AAIEEVEMEDFDANI | 2006 | P49750 | |
| EADLATDERADVQME | 1181 | P11137 | |
| DRMEVQEQEEDISSL | 3216 | P78527 | |
| LNEEVMVADDLESER | 331 | Q9BZF9 | |
| MDVAEENRAIDEVNR | 171 | Q8N831 | |
| EILAADEVLQESEMR | 56 | Q9UQR1 | |
| ARDDMDFTELIVTDD | 161 | P0DMS9 | |
| EDLSQAAEQDEMRLE | 71 | P61278 | |
| ANRLAEELVAEEERM | 156 | Q49AM3 | |
| VDEDVVELVQFLNMR | 26 | Q6IPR3 | |
| VVVDLQDMDIFAAER | 2156 | Q5THJ4 | |
| DAMISIRQEIADIEE | 921 | P23378 | |
| MAEDEAETIGNLIEE | 441 | O00629 | |
| LEAELRNMQDVVEDF | 221 | O95678 | |
| EEAEREHQEAVEMAE | 636 | Q96M32 | |
| NEAARMAALVEAEKE | 121 | Q5VU43 | |
| DRVEMAVEVSEEGAQ | 361 | Q14324 |